<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">92879</article-id>
<article-id pub-id-type="doi">10.7554/eLife.92879</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92879.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology and Inflammation</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Downregulation of <italic>Let-7</italic> miRNA promotes Tc17 differentiation and emphysema via de-repression of RORγt</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Erice</surname>
<given-names>Phillip A.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Xinyan</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seasock</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robertson</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tung</surname>
<given-names>Hui-Ying</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Perez-Negron</surname>
<given-names>Melissa A.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lotlikar</surname>
<given-names>Shivani L.</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Corry</surname>
<given-names>David B</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kheradmand</surname>
<given-names>Farrah</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="aff" rid="a5">5</xref>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rodriguez</surname>
<given-names>Antony</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a6">6</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Immunology Graduate Program, Baylor College of Medicine</institution>, Houston, TX, 77030</aff>
<aff id="a2"><label>2</label><institution>Department of Medicine, Immunology &amp; Allergy Rheumatology, Baylor College of Medicine Houston TX</institution>, 77030</aff>
<aff id="a3"><label>3</label><institution>Dan Duncan Comprehensive Cancer Center, Baylor College of Medicine Houston</institution>, TX, 77030</aff>
<aff id="a4"><label>4</label><institution>Department of Pathology and Immunology, Baylor College of Medicine Houston</institution>, TX, 77030</aff>
<aff id="a5"><label>5</label><institution>Department of Medicine, Section of Pulmonary and Critical Care, Baylor College of Medicine. Houston</institution>, TX, 77030</aff>
<aff id="a6"><label>6</label><institution>Center for Translational Research on Inflammatory Diseases, Michael E. Debakey, Baylor College of Medicine</institution>, Houston, TX, 77030</aff>
<aff id="a7"><label>7</label><institution>Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University</institution>. Guangzhou, Guangdong Province, P.R. China</aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Rath</surname>
<given-names>Satyajit</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Indian Institute of Science Education and Research (IISER)</institution>
</institution-wrap>
<city>Pune</city>
<country>India</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Rath</surname>
<given-names>Satyajit</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Indian Institute of Science Education and Research (IISER)</institution>
</institution-wrap>
<city>Pune</city>
<country>India</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Author Correspondence: <email>antony.rodriguez@bcm.edu</email></corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-02-07">
<day>07</day>
<month>02</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP92879</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-10-12">
<day>12</day>
<month>10</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-10-21">
<day>21</day>
<month>10</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.12.562059"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Erice et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Erice et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-92879-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Environmental air irritants including nanosized carbon black (nCB) can drive systemic inflammation, promoting chronic obstructive pulmonary disease (COPD) and emphysema development. The <italic>let-7</italic> family of miRNAs is associated with IL-17-driven T cell inflammation, a canonical signature of lung inflammation. Recent evidence suggests the <italic>let-7</italic> family is downregulated in patients with COPD, however, how they cause emphysema remains unclear. Here we show that overall expression of the <italic>let-7</italic> miRNA clusters, <italic>let-7b/let-7c2</italic> and <italic>let-7a1/let-7f1/let-7d</italic>, are reduced in the lungs and T cells of smokers with emphysema as well as in mice with cigarette smoke (CS)- or nCB-elicited emphysema. We demonstrate that loss of the <italic>let-7b/let-7c2-</italic>cluster in T cells predisposed mice to exaggerated CS- or nCB-elicited emphysema. Furthermore, ablation of the <italic>let-7b/let-7c2-cluster</italic> enhanced CD8<sup>+</sup>IL17a<sup>+</sup> T cells (Tc17) formation in emphysema development in mice. Additionally, transgenic mice overexpressing <italic>let-7</italic> in T cells were resistant to Tc17 and CD4<sup>+</sup> T cells (Th17) development when exposed to nCB. Mechanistically, our findings reveal the master regulator of Tc17/Th17 differentiation, RAR-related orphan receptor gamma t (RORγt), as a direct target of <italic>let-7</italic> miRNA in T cells. Overall, our findings shed light on the <italic>let-7</italic>/RORγt axis as a braking and driving regulatory circuit in the generation of Tc17 cells and suggests a novel therapeutic approach for tempering the augmented IL-17-mediated response in emphysema.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This version corrected the spelling in abstract.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Chronic obstructive pulmonary disease (COPD) ranks as the third leading cause of mortality and is projected to account for over a billion deaths by the end of the twenty-first century (GBD Chronic Respiratory Disease Collaborators, 2020; <italic>Findings from the Global Burden of Disease Study 2017</italic>, 2019; <xref ref-type="bibr" rid="c29">Laniado-Laborín, 2009</xref>). Currently, there are no treatment options to reverse emphysema, the most clinically significant variant of COPD, which often is progressive despite smoking cessation (Bhavani et al., 2015; Anthonisen et al., 2002).</p>
<p>Inhalation of fine particulate matter smaller than 2.5 microns (PM2.5) found in outdoor and indoor air pollution as well as tobacco smoke are risk factors for COPD development (Adeloye et al., 2022; Eisner et al., 2010; Hu et al., 2010). We have previously shown that nano-sized carbon black (nCB), a noxious chemical constituent of PM2.5 found in the lungs of smokers, activates macrophages and dendritic cells orchestrating a pathogenic T cell-dependent inflammatory response and emphysema in mice (<xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>; <xref ref-type="bibr" rid="c53">You et al., 2015</xref>; <xref ref-type="bibr" rid="c44">Shan et al., 2009</xref>; C.-Y. Chang et al., 2022).</p>
<p>Research over the last decade has pointed to the importance of dysfunctional inflammatory T cells in human COPD lung tissue and animal models of emphysema (<xref ref-type="bibr" rid="c16">Grumelli et al., 2004</xref>; <xref ref-type="bibr" rid="c51">Xu et al., 2012</xref>; <xref ref-type="bibr" rid="c50">Williams et al., 2021</xref>). Aberrant T cells are implicated in impaired host defense, exaggerated inflammation, and loss of self-tolerance in COPD (<xref ref-type="bibr" rid="c50">Williams et al., 2021</xref>; Chen et al., 2023; Hogg et al., 2004; Maeno et al., 2007; <xref ref-type="bibr" rid="c51">Xu et al., 2012</xref>). In this regard, we and others have demonstrated the role and pathogenicity of activated IFN-γ and IL-17-secreting subsets of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes including Th1, Th17, and Tc1 cells in clinical isolates and in mice with COPD (<xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>; <xref ref-type="bibr" rid="c53">You et al., 2015</xref>; <xref ref-type="bibr" rid="c44">Shan et al., 2009</xref>; S.-H. <xref ref-type="bibr" rid="c31">Lee et al., 2007</xref>; Kheradmand et al., 2023). The IL-17-secreting Th17 cells are particularly important as they promote the destruction of lung epithelium and recruitment of macrophages and neutrophils which then release proteolytic enzymes such as matrix metalloproteinases (MMPs) involved in the degradation of the lung structural matrix (<xref ref-type="bibr" rid="c3">Barnes, 2016</xref>; <xref ref-type="bibr" rid="c20">Hoenderdos &amp; Condliffe, 2013</xref>). We previously demonstrated that intranasal inhalation of nCB in mice is sufficient to induce emphysema by stimulating T cell activation by dendritic cells and macrophages in mice. Moreover, we found that genetic ablation of IL-17a can attenuate nCB- or cigarette smoke-induced alveolar destruction and airway inflammation (<xref ref-type="bibr" rid="c46">Shan et al., 2012</xref>; <xref ref-type="bibr" rid="c53">You et al., 2015</xref>). More recently, IL-17A and IL-17F secreting CD8<sup>+</sup> T cell (Tc17) subpopulation has been shown to play a critical role in the pathogenesis of several autoimmune and inflammatory disorders (<xref ref-type="bibr" rid="c15">Globig et al., 2022</xref>; <xref ref-type="bibr" rid="c21">Huber et al., 2013</xref>; Srenathan et al., 2016).</p>
<p>Both Th17 and Tc17, require the fate-deterministic transcription factor RAR-related orphan receptor gamma t (RORγt, encoded by <italic>Rorc</italic>) for differentiation and production of IL-17a (<xref ref-type="bibr" rid="c23">Ivanov et al., 2007</xref>). RORγt is the best-studied positive transcriptional regulator of IL-17a and IL-17f (<xref ref-type="bibr" rid="c22">Ivanov et al., 2006</xref>). In accordance with the importance of IL-17a transcription, RORγt expression has also been reported to be elevated in COPD patients and in mouse models of COPD (<xref ref-type="bibr" rid="c8">Chu et al., 2011</xref>; <xref ref-type="bibr" rid="c32">Li et al., 2015</xref>). However, the upstream pathophysiologic mechanisms that contribute to the induction of RORγt and differentiation of Tc17 cells in COPD have not been well elucidated.</p>
<p>We previously reported that <italic>miR-22</italic> inhibits HDAC4, promoting antigen-presenting cell activation (APC) in the lungs and inducing Th17-mediated emphysema in response to CS or nCB in mice (<xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>). Additional miRNAs that control APC and/or T cell driven IL-17a<sup>+</sup> inflammation have been identified by others including the <italic>let-7</italic> miRNA family (<xref ref-type="bibr" rid="c34">Mai et al., 2012</xref>; <xref ref-type="bibr" rid="c2">Angelou et al., 2020</xref>). MicroRNA expression-based studies have shown frequent downregulation of members of the <italic>let-7</italic> miRNA family, including <italic>let-7a, let-7b, let-7c</italic>, <italic>let-7d</italic>, l<italic>et-7e</italic>, and <italic>let-7f</italic> in human emphysematous lung tissue and in murine models of emphysema, but the mechanism(s) of action remain ill-defined (Christenson et al., 2013; <xref ref-type="bibr" rid="c39">Pottelberge et al., 2011</xref>; <xref ref-type="bibr" rid="c9">Conickx et al., 2017</xref>; <xref ref-type="bibr" rid="c24">Izzotti et al., 2009</xref>). <italic>Let-7</italic> microRNA genes are encoded across eight loci either as single genes or as polycistronic clusters which have confounded their analysis <italic>in vivo</italic> (<xref ref-type="bibr" rid="c41">Rodriguez et al., 2004</xref>). Previous studies used <italic>Lin28b</italic> transgenic overexpression in T cells to block the maturation and processing of <italic>the let-7</italic> miRNA family. They showed an inhibitory role of <italic>let-7</italic> family in Th17-driven response in murine model of experimental autoimmune encephalomyelitis (EAE) (<xref ref-type="bibr" rid="c2">Angelou et al., 2020</xref>).</p>
<p>Here we found that <italic>let-7</italic> miRNA, notably the <italic>let-7a3/let-7b</italic> and <italic>let-7a1/let-7f1/let-7d</italic> clusters, are suppressed in the T cells isolated from lungs of emphysema patients. Consistently, the analogous murine <italic>let-7b/let-7c2-</italic> (<italic>let-7bc2</italic>) and <italic>let-7a1/f1/d1-</italic> (<italic>let-7afd</italic>) clusters were similarly downregulated in pre-clinical emphysema models. We engineered mouse models with the specific loss-of-function (LOF) mutations of the <italic>let-7bc2</italic> or <italic>let-7afd</italic> clusters (<italic>let-7bc2<sup>LOF</sup></italic>and <italic>let-7afd<sup>LOF</sup></italic>, respectively) in T cells as well as an inducible <italic>let-7g</italic> gain-of-function (GOF) (<italic>let-7<sup>GOF</sup></italic>) model to determine the T cell-intrinsic role of <italic>let-7</italic> miRNA in emphysema pathogenesis. Deletion of <italic>let-7</italic> miRNA in T cells worsened alveolar damage elicited by inhalation of CS or nCB, and increased infiltration of immune cells in the airways, including IL-17-producing CD8<sup>+</sup> T (Tc17) cells. Mechanistically, we found that <italic>let-7</italic> controls type 17 differentiation by directly targeting the lineage-determining transcription factor, RORγt. In support of this conclusion, <italic>let-7<sup>GOF</sup></italic> mice were resistant to nCB-mediated induction of RORγt and Tc17 responses. Thus, we show a previously unappreciated role for <italic>let-7</italic> miRNA as a repressor of RORγt and a molecular brake to the IL-17a-mediated T cell inflammation in emphysema.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>The <italic>let-7bc2</italic>- and <italic>let-7afd-clusters</italic> are downregulated in lungs and T cells in COPD</title>
<p>To explore the involvement of <italic>let-7</italic> in emphysema, we scrutinized the genomic locations and transcriptional annotation of <italic>let-7</italic> members frequently downregulated in lung T cells isolated from smoker’s lungs as well as mouse models of emphysema. This combined approach showed close linkage and high conservation of two <italic>Let-7</italic> clusters encoded from long intergenic non-coding RNA (linc)-like precursors in humans and mice (<xref rid="fig1" ref-type="fig">Figure 1A</xref>). To shed light on whether these <italic>Let-7</italic> clusters are downregulated in patients with COPD, we analyzed a published (GSE57148) lung RNA-seq dataset obtained from COPD (N=98 and control (N=91) subjects (<xref ref-type="bibr" rid="c28">Kim et al., 2015</xref>). Our analysis identified significant downregulation of the <italic>Mirlet7ahg</italic> and <italic>Mirlet7bhg</italic> gene cluster transcripts in COPD compared to control subjects (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). We carried out quantitative PCR (qPCR) detection of <italic>Let-7a,</italic> which is encoded by both clusters, in lung tissue samples of smokers with emphysema and non-emphysema controls, detecting significant downregulation of <italic>Let-7a</italic> in emphysema samples relative to controls (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). Because <italic>Let-7</italic> has been shown to participate in IL-17<sup>+</sup> T cell responses (<xref ref-type="bibr" rid="c2">Angelou et al., 2020</xref>; <xref ref-type="bibr" rid="c17">Guan et al., 2013</xref>; <xref ref-type="bibr" rid="c36">Newcomb et al., 2015</xref>), we next sought to determine if the expression pattern of <italic>Mirlet7ahg</italic> and <italic>Mirlet7bhg</italic>-derived <italic>Let-7</italic> members are impaired in purified CD4<sup>+</sup> T cells from emphysematous lungs. In support of our original hypothesis, the CD4<sup>+</sup> T cell expression of <italic>Let-7a</italic>, <italic>Let-7b</italic>, <italic>Let-7d</italic>, and <italic>Let-7f</italic> were all inversely correlated with more severe emphysema distribution in the lungs as determined by CT scan (<xref rid="fig1" ref-type="fig">Figure 1D</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Repression of <italic>Let-7</italic> miRNA gene clusters in lung T cells from COPD patients and murine models of emphysema.</title>
<p>(A) Schematic representation of the polycistronic transcripts for the <italic>Let-7a1/Let-7f1/Let-7d-</italic> and <italic>Let-7b/Let-7a3-</italic>clusters in humans and <italic>let-7a1/let-7f1/let-7/d-</italic> and l<italic>et-7b/let-7c2-</italic>clusters in mice. (B) <italic>in silico</italic> analysis of <italic>Mirlet7a1hg</italic> and <italic>Mirlet7bhg</italic> from the publicly available lung transcriptome dataset from RNA-seq of COPD and control patients (GEO: GSE57148). (C) Quantitative RT-PCR (qPCR) of mature <italic>Hsa-Let-7a</italic> from resected lung tissue of COPD (n=15) and control subjects (n=11). (D) qPCR and regression analysis of <italic>Hsa-Let-7a, Hsa-Let-7b, Hsa-Let-7d, and Hsa-Let-7f</italic> expression to emphysema severity score based on CT: 0=no, 1=upper lobes only, 2=upper/middle lobes, 3=extensive pan lobular emphysema (n=19). (E) Schematic diagram of experimental emphysema in mice induced by either intranasal (i.n.) instillation of nCB or exposure to CS by whole-body inhalation (w.b.i.). (F-H) qPCR analysis for <italic>pri-let-7a1/f1/d</italic> and <italic>pri-let-7b/c2</italic> from lung tissue or lung-derived CD8<sup>+</sup> and CD4<sup>+</sup> T cells of mice with emphysema elicited by (F) nCB- or (G-H) CS (n=3-6 per group). Data are representative of three independent experiments displayed as mean±SEM. Mann-Whitney (B,C) or Student’s t-test (F,G,H). *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Next, we elucidated <italic>let-7a1/let-7f1/let-7d-</italic> and <italic>let-7b/let-7c2-</italic>clusters expression (herein referred to as <italic>let-7afd</italic> and <italic>let-7bc2</italic> respectively) in murine models of CS- or nCB-induced emphysema respectively (<xref rid="fig1" ref-type="fig">Figure 1E</xref>). Paralleling our observations in human COPD and emphysema, mice with CS- or nCB-induced emphysema exhibited reduced expression levels of <italic>pri-let7afd</italic> and <italic>pri-let7bc2</italic> transcripts in the lung and from isolated lung CD4<sup>+</sup> and CD8<sup>+</sup> T cells (<xref rid="fig1" ref-type="fig">Figure 1F,G</xref>,H). Collectively, our expression results indicate suppression of <italic>let-7afd</italic> and <italic>let-7bc2-</italic> clusters in the lung and T cells in human and pre-clinical models of emphysema.</p>
</sec>
<sec id="s2b">
<title>Conditional deletion of the <italic>let7bc2</italic>-cluster in T cells enhances nCB- or CS-induced emphysema</title>
<p>To investigate the <italic>in vivo</italic> requirement of the <italic>let-7bc2-cluster</italic> within T cells, we generated conditional ready floxed mice (<italic>let-7bc2<sup>flox/flox</sup></italic>). We then crossed <italic>let7-bc2<sup>flox/flox</sup></italic> mice with <italic>CD4-Cre</italic> mice to generate <italic>let-7bc2<sup>flox/flox</sup></italic>; <italic>CD4-Cre</italic> LOF mice (denoted as <italic>let-7bc2<sup>LOF</sup></italic> mice hereafter) (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). This approach allowed us to conditionally delete the <italic>let-7bc2</italic> cluster in all T cells derived from the CD4<sup>+</sup>CD8<sup>+</sup> double-positive (DP) stage (P. <xref ref-type="bibr" rid="c30">Lee et al., 2001</xref>; <xref ref-type="bibr" rid="c47">Shi &amp; Petrie, 2012</xref>). We confirmed that <italic>let-7bc2<sup>LOF</sup></italic>mice exhibit robust conditional deletion of the <italic>let-7bc2</italic> cluster in DP thymocytes and peripheral CD8<sup>+</sup> T and CD4<sup>+</sup> T cells (<xref rid="fig2" ref-type="fig">Figure 2B</xref> and data not shown). Our <italic>let- 7bc2<sup>LOF</sup></italic> adult mice were born at the expected Mendelian frequency and did not show any overt histopathologic or inflammatory changes in lungs histopathology up to 1 year of age in comparison to <italic>let-7bc2<sup>f/f</sup></italic> control mice (Figure 1-figure supplement 1A,B,C,D and data not shown). Furthermore, quantification of major immune populations and T cell subsets by flow cytometry in <italic>let-7bc2<sup>LOF</sup></italic> were comparable to control mice under baseline conditions and with moderate aging (Figure 1-figure supplement 1A,B,C,D).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Deletion of the <italic>let7bc2</italic> cluster in T cells enhances nCB- or CS-triggered emphysema.</title>
<p>(A) Schematic representation of CD4-Cre (<italic>let-7bc2<sup>LOF</sup></italic>) or <italic>let-7bc2<sup>f/f</sup></italic> (Control) mice. (B) qPCR analysis of pri-miRNA transcript for <italic>pri-let-7bc2</italic> from flow-sorted live, TCRβ<sup>+</sup>, CD4<sup>+</sup>CD8<sup>+</sup> double-positive (DP) thymocytes of control and <italic>let-7bc2<sup>LOF</sup></italic> mice (n=3-5 per group). (C-G) Control and <italic>let-7bc2<sup>LOF</sup></italic> mice were exposed to vehicle (PBS) or nCB for 4 weeks, or alternatively air or cigarette smoke by whole body inhalation of cigarette smoke (CS) for 16 weeks. (C) Representative H&amp;E stained lung sections from PBS-, nCB-, or CS-exposed mice as indicated on each panel (x20 magnification; scale bars, 50µm). (D-E) Mean linear intercept (MLI) measurement of lung morphometry. (F) Total and differential cell counts from bronchoalveolar lavage (BAL) fluid from controls and nCB-emphysemic mice (n=4-7 per group). (G) <italic>Mmp9</italic> and <italic>Mmp12</italic> mRNA expression from BAL cells of air- and smoke-exposed control and <italic>let-7bc2<sup>LOF</sup></italic> mice (n=4-6 per group). Data are representative of at least three independent experiments displayed as mean±SEM using Student’s t-test (B) or two-way ANOVA with <italic>post-hoc</italic> Tukey correction (D,E,F,G). *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We next exposed <italic>let-7bc2<sup>LOF</sup></italic> and <italic>let-7bc2<sup>f/f</sup></italic> control mice to nCB or CS and examined the lungs under the context of experimental emphysema. Histomorphometry measurements of mean linear intercept (MLI) from hematoxylin and eosin (H&amp;E)-stained sections revealed that the enlargement of alveolar spaces sustained from either nCB- or CS-exposure was exaggerated in <italic>let-7bc2<sup>LOF</sup></italic> mice relative to controls (<xref rid="fig2" ref-type="fig">Figure 2C-E</xref>). Chronic inflammation in emphysema is characterized by the recruitment of macrophages and neutrophils to the lung tissue and airways (<xref ref-type="bibr" rid="c38">Peleman et al., 1999</xref>; <xref ref-type="bibr" rid="c43">Senior &amp; Anthonisen, 1998</xref>). Internally consistent with MLI measurements, <italic>let-7bc2<sup>LOF</sup></italic> mice treated with nCB showed significantly increased airway infiltration of macrophages and neutrophils in BAL fluid as compared to wild-type control animals (<xref rid="fig2" ref-type="fig">Figure 2F</xref>). Concomitant with these findings, expression levels of <italic>Mmp9</italic> and <italic>Mmp12</italic>, which are secreted by macrophages and neutrophils to degrade elastin and mediate alveolar damage, were elevated in airways of <italic>let-7bc2<sup>LOF</sup></italic> mice exposed to CS versus controls (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). Collectively, our data suggests that the <italic>let-7bc2-</italic>cluster within T cells protects by dampening airway destruction and inflammation because the absence of this cluster worsens the severity of experimental emphysema in mice.</p>
</sec>
<sec id="s2c">
<title>The <italic>let-7bc2</italic> miRNA cluster negatively regulates TC17 inflammation in emphysema</title>
<p>We sought to identify the T cell-intrinsic mechanisms that underlie the exaggerated inflammation observed in emphysematous <italic>let7bc2<sup>LOF</sup></italic> mice. We focused on the IL-17-mediated T cell response because it promotes neutrophil and macrophage recruitment in the lungs (<xref ref-type="bibr" rid="c4">Beringer et al., 2016</xref>; <xref ref-type="bibr" rid="c48">Veldhoen, 2017</xref>; <xref ref-type="bibr" rid="c46">Shan et al., 2012</xref>). Previously, we established the induction of CD4<sup>+</sup>IL17<sup>+</sup> (Th17) cells along with CD4<sup>+</sup>IFNg<sup>+</sup> (Th1) cells in mice with chronic nCB exposure (<xref ref-type="bibr" rid="c53">You et al., 2015</xref>), however whether nCB similarly induces CD8<sup>+</sup>IL17a<sup>+</sup> T cells (Tc17) or cytotoxic T cells (Tc1) had not been studied. The flow cytometric profiling of lung T cells revealed enriched proportions and counts of Tc1 and Tc17 cells in mice with nCB-emphysema and we confirmed the induction of Th17 and Th1 cells (<xref rid="fig3" ref-type="fig">Figure 3A-B</xref> control PBS and control nCB). These findings suggests that nCB elicits both the type 17 and type 1 T cell responses, consistent with CS and elastase pre-clinical models of emphysema (<xref ref-type="bibr" rid="c54">Zhang et al., 2019</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title><italic>In vivo</italic> T cell ablation of the <italic>let-7bc2</italic>-cluster enhances Tc17 inflammatory response to nCB-emphysema.</title>
<p>Representative flow plots with percentage and counts of live TCRβ<sup>+</sup> (A) CD8<sup>+</sup>IL-17a<sup>+</sup> and CD8<sup>+</sup>IFNγ<sup>+</sup>, (B) CD8<sup>+</sup>IFNγ<sup>+</sup>GzmA<sup>+</sup>, (C) CD4<sup>+</sup>IL-17a<sup>+</sup> and CD4<sup>+</sup>IFNγ<sup>+</sup>, and (D) CD4<sup>+</sup> Foxp3<sup>+</sup>CD25<sup>+</sup> cells from the lungs of control PBS vehicle- (n=5-6), control nCB- (n=6), and <italic>let-7bc2<sup>LOF</sup></italic> nCB- exposed mice. Data are representa-tive of three independent experiments displayed as mean±SEM using ANOVA with <italic>post-hoc</italic> Sidak correction. *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We next interrogated the regulatory role of the <italic>let-7bc2</italic>-cluster in the type 17 and type 1 responses generated from exposure to nCB. Interestingly, <italic>let-7bc2<sup>LOF</sup></italic> mice showed increased CD8<sup>+</sup>IL17a<sup>+</sup> Tc17 cells relative to nCB control animals. In contrast, CD8<sup>+</sup>IFN<sup>+</sup> and GZMA<sup>+</sup> Tc1 populations remained unperturbed with absence of the <italic>let-7bc2</italic> cluster, suggestive of a more refined regulatory role on Tc17 differentiation (<xref rid="fig3" ref-type="fig">Figure 3A-B</xref>). There were no significant differences in either Th1 or Th17 cells when comparing nCB-treated <italic>let-7bc2<sup>LOF</sup></italic> to wild-type controls, indicating the <italic>let-7bc2</italic> cluster was dispensable for their generation (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). Regulatory T cells form a dynamic axis with Tc17/Th17 cells and act as a counterbalance to lung inflammation in emphysema (<xref ref-type="bibr" rid="c13">Duan et al., 2016</xref>; <xref ref-type="bibr" rid="c26">Jin et al., 2014</xref>). Therefore, we examined whether Tc17 cell alterations were driven by the <italic>let-7bc2</italic> cluster acting on regulatory T cells (Tregs). The <italic>let-7bc2<sup>LOF</sup></italic> mice showed no significant difference in Tregs subset relative to controls in our model (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). Together, our data support the notion that deletion of the <italic>let-7bc2-</italic>cluster is insufficient to provoke Tc17 cell generation under homeostatic conditions. However, under the context of chronic inflammation in emphysema, the loss of <italic>let-7bc2</italic>-cluster is intrinsic for the potentiation of T cells towards Tc17 differentiation.</p>
</sec>
<sec id="s2d">
<title>The <italic>let-7</italic> family directly inhibits RORγt expression governing Tc17 differentiation in emphysema</title>
<p>We utilized the TargetScan predictive algorithm to identify putative <italic>let-7</italic> microRNA targets that are known to control the IL-17-mediated T cell response (<xref ref-type="bibr" rid="c1">Agarwal et al., 2015</xref>). This analysis revealed that the 3’UTR region of <italic>Rorc</italic>, encoding RORγt, contains an evolutionarily conserved and complementary motif for the <italic>let-7</italic> miRNA family (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). Thus, we examined if <italic>let7bc2-</italic> cluster loss in T cells would stimulate and enhance RORγt. Initially, we carried out flow cytometric quantification for RORγt in thymocyte, splenic, and lung T cells of naïve control and <italic>let7bc2<sup>LOF</sup></italic>mice up to 6-months of age. Our interrogation of RORγt mean fluorescent intensity (MFI) by flow cytometry showed induction of RORγt in single-positive CD8<sup>+</sup> and CD4<sup>+</sup> thymocytes, as well as peripheral splenic CD8<sup>+</sup> and CD4<sup>+</sup> T cells (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). However, RORγt levels appeared unchanged in purified lung CD8<sup>+</sup> T cells and CD4<sup>+</sup> T cells of naive <italic>let-7bc2<sup>LOF</sup></italic> mice, alluding to a compensatory effect in homeostatic lung T cells (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). Since we and others have shown that miRNAs are frequently associated with stress-dependent phenotypes, we posited that emphysematous <italic>let-7bc2<sup>LOF</sup></italic>T cells are poised towards induction of RORγt and production of IL17<sup>+</sup> subsets after challenge with nCB. Indeed, nCB-emphysematous <italic>let-7bc<sup>LOF</sup></italic>mice exhibited enhanced RORγt protein levels in both CD8<sup>+</sup> and CD4<sup>+</sup> T cells relative to control mice with emphysema (<xref rid="fig4" ref-type="fig">Figure 4C</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Deletion of either the <italic>let7bc2-</italic> or <italic>let7afd-</italic>cluster in T cells enhances RORγt expression <italic>in vivo</italic>.</title>
<p>(A) Left: Schematic representation of the murine <italic>Rorc</italic> 3’UTR with <italic>let-7</italic> miRNA binding sites as identified by TargetScan. Right: Schematic of a conserved <italic>let-7</italic> miRNA target sequence in the 3’UTR of <italic>Rorc</italic>. (B-C) Flow analysis of RORγt expression by MFI quantification in live TCRβ<sup>+</sup>CD8<sup>+</sup> or CD4<sup>+</sup> T cells from indicated tissues of (B) naïve control and <italic>let-7bc2<sup>LOF</sup></italic> mice or (C) nCB-treated lungs by representative flow plot and MFI quantification (n=5 per group). (D) RORγt expression by MFI quantification in naïve mice <italic>let-7afd<sup>LOF</sup></italic> mice thymus, spleen, and lungs (n=3-4 per group), or (E) nCB- ex-posed lungs (n=5 per group). Data are representative of at least three independent experiments displayed as mean±SEM using student’s t-test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Because we had found that the <italic>let-7afd-</italic>cluster is downregulated in T cells isolated from COPD lungs in human and mice, and that the <italic>let-7</italic> family operates with some functional redundancy, we generated mice with conditional deletion of the <italic>let7afd-</italic>cluster in T cells (<italic>let-7afd<sup>f/f</sup>; CD4-Cre</italic>). The <italic>let-7afd<sup>f/f</sup>; CD4-Cre</italic> (<italic>let7afd<sup>LOF</sup></italic>) mice aged up to 6-months did not exhibit lung histopathology nor inflammatory changes (data not shown). Of particular interest, ablation of the <italic>let-7afd-</italic>cluster enhanced levels of RORγt in thymic and peripheral T cells of mice (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). Overall, this indicates that independent <italic>let-7</italic> clusters restrain RORγt expression levels from thymic development to peripheral T cells under homeostatic conditions. Next, we determined whether loss of <italic>let-7afd</italic>-cluster in T cells likewise sensitizes mice towards induction of RORγt in nCB-emphysema. Intranasal administration of nCB provoked increased RORγt expression in lung T cells of <italic>let-7afd<sup>LOF</sup></italic>mice as compared to <italic>let-7afd<sup>f/f</sup></italic> control mice (<xref rid="fig4" ref-type="fig">Figure 4E</xref>), supporting overlapping functionality between the <italic>let-7bc2</italic> and <italic>let-7afd-</italic>clusters in repression of RORγt within T cells.</p>
<p>To confirm that the <italic>let-7</italic> family negatively regulates Tc17 cell differentiation, at least in part, cell autonomously in CD8<sup>+</sup> T cells, we purified naïve CD8<sup>+</sup> T cells from <italic>let-7bc2<sup>LOF</sup></italic> and control mice spleens and cultured these cells <italic>in vitro</italic> in the presence of Tc17 polarizing (TGFβ, IL-6, anti- IFNγ, IL-23, and IL-1β) or Tc1 polarizing (IL-2) conditions (Flores-Santibáñez et al., 2018). Our flow cytometric analysis confirmed the enhanced commitment of <italic>let-7</italic>-cluster deficient CD8<sup>+</sup> T cells towards Tc17 cells and IL-17a<sup>+</sup> production relative to control CD8<sup>+</sup> T cells (<xref rid="fig5" ref-type="fig">Figure 5A-B</xref>). Moreover, enhanced Tc17 cell differentiation mirrored the increased IL-17a detected in the supernatant from <italic>in vitro</italic> polarized cells as quantified by ELISA (<xref rid="fig5" ref-type="fig">Figure 5C</xref>). Parallel assessment of Tc1 differentiation did not detect a difference in CD8<sup>+</sup>IFNγ<sup>+</sup> cells (<xref rid="fig5" ref-type="fig">Figure 5A</xref> and <xref rid="fig5" ref-type="fig">Figure 5D</xref>). Altogether, these data recapitulated our <italic>in vivo</italic> findings that the <italic>let-7bc2</italic> cluster negatively regulates Tc17 response but is dispensable in Tc1 cells. Finally, to determine whether Tc17 differentiation is likewise controlled by the <italic>let-7afd</italic> cluster, we cultured naive CD8<sup>+</sup> splenocytes from <italic>let-7afd<sup>LOF</sup></italic> and controls under Tc17 conditions. As we had observed with <italic>let-7bc2<sup>LOF</sup>,</italic> absence of the <italic>let-7afd</italic> cluster in T cells further enhanced differentiation towards Tc17 cells as quantified by flow cytometry and ELISA (<xref rid="fig5" ref-type="fig">Figure 5E-F</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title><italic>Let-7</italic> restricts Tc17 <italic>in vitro</italic> differentiation in part via direct targeting of <italic>Rorc</italic> mRNA.</title>
<p>(A) Representative flow plots of live TCRβ<sup>+</sup> CD8<sup>+</sup>, IL-17a<sup>+</sup> and IFNγ<sup>+</sup> populations from Tc1 and Tc17 polarized naïve splenic CD8<sup>+</sup> cells from control and <italic>let-7bc2<sup>LOF</sup></italic> mice and (B) quantification of CD8<sup>+</sup>IL-17a<sup>+</sup> cells (n=5 per group). (C) ELISA of IL-17a from the supernatant of Tc1 and Tc17 polarized control and <italic>let-7bc2<sup>LOF</sup></italic> cells (n=5-6 per group). (D) Flow quantification of CD8<sup>+</sup>IFNγ<sup>+</sup> populations in Tc1 and Tc17 polarized control and <italic>let-7bc2<sup>LOF</sup></italic> cells (n=5 per group). (E) Representative flow plots of CD8<sup>+</sup>IL-17a<sup>+</sup> population frequency in Tc17 polarized cells indicated mice, and (E) quantification of CD8<sup>+</sup>IL-17a<sup>+</sup> cells from control and <italic>let-7afd<sup>LOF</sup></italic> mice polarized under Tc1 or Tc17 conditions. (F) ELISA of IL-17a from control Tc1 (n=4), control Tc17 (n=4), and <italic>let-7afd<sup>LOF</sup></italic> Tc17 (n=3) polarized cells. (G) Representative flow plot and quantification of RORγt from Tc0 or Tc17 differentiated naïve splenic CD8<sup>+</sup> T cells isolated from control and <italic>let-7bc2<sup>LOF</sup></italic> mice (n=5 per group). (H) Control (<italic>Rorc</italic> WT) or binding site mutant (<italic>Rorc</italic> Mut) 3’ UTRs of <italic>Rorc</italic> were cloned downstream of the renilla luciferase reporter. Plasmids were cotransfected with either a control-miR (black bars) or <italic>let-7b</italic> mimic (blue bars) duplex into cultured cells. Reporter activity was measured 24 hours after transfection and normalized to firefly activity. Data are representative of three independent experiments (A-G) or carried out in triplicate (H) and displayed as mean±SEM using student’s t-test. *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Next, we focused on <italic>Rorc</italic> as a potential direct target of <italic>let-7</italic>, which could mechanistically mediate enhanced Tc17 differentiation in <italic>let7bc2<sup>LOF</sup></italic> mice. Towards this objective, tested whether <italic>let-7bc2<sup>LOF</sup></italic>naïve CD8<sup>+</sup> T cells show elevated RORγt expression under either Tc0 or Tc17 differentiation conditions. In agreement with enhanced Tc17 differentiation, RORγt expression was differentially and significantly upregulated under both Tc0 and Tc17 differentiation conditions in <italic>let-7bc2<sup>LOF</sup></italic> cells relative to controls (<xref rid="fig5" ref-type="fig">Figure 5G</xref>). To determine whether <italic>let-7</italic> directly represses <italic>Rorc</italic> mRNA levels we cloned the 3’UTR of <italic>Rorc</italic> into luciferase constructs. These reporter assays with <italic>let-7b</italic> expressing cells independently confirmed that <italic>let-7b</italic> represses <italic>Rorc</italic> (<xref rid="fig5" ref-type="fig">Figure 5H</xref>, left). Furthermore, deletion of the putative <italic>let-7</italic> binding sequence (<xref rid="fig4" ref-type="fig">Figure 4A</xref>) abrogated repression by <italic>let-7b</italic> (<xref rid="fig5" ref-type="fig">Figure 5H</xref>, right), thus confirming <italic>Rorc</italic> as a functional target of <italic>let-7</italic> miRNA. Overall, these <italic>in vitro</italic> experiments readily recapitulated an upstream regulatory role for <italic>let-7</italic> in Tc17 differentiation, mediated in part, via direct suppression of RORγt.</p>
</sec>
<sec id="s2e">
<title>Enforced expression of <italic>let-7</italic> tempers RORγt T cell expression levels in experimental emphysema</title>
<p>To explore a potential protective role of <italic>let-7</italic> miRNA in experimentally induced emphysema, we generated mice which allowed for selective induction of <italic>let-7</italic> activity in T cells using the published <italic>rtTA-iLet7</italic> mice (<xref ref-type="bibr" rid="c56">Zhu et al., 2011</xref>; Belteki et al., 2005). We bred the <italic>rtTA-iLet7</italic> mice to <italic>CD4-Cre</italic> (here in referred to as <italic>let-7<sup>GOF</sup></italic>) to allow Cre-loxP/doxycycline dependent <italic>let-7g</italic> overexpression in thymic DP-derived T cells (<xref rid="fig6" ref-type="fig">Figure 6A</xref>). Steady-state <italic>let-7<sup>GOF</sup></italic> and control (<italic>rtTA-iLet7</italic>) mice were examined for compromised RORγt protein levels within thymocytes and peripheral T cells. Providing further evidence of <italic>let-7</italic>-dependent regulation of <italic>Rorc</italic>, protein levels of RORγt were suppressed in CD8<sup>+</sup> and CD4<sup>+</sup> T cells of <italic>let-7<sup>GOF</sup></italic> mice relative to controls (<xref rid="fig6" ref-type="fig">Figure 6B</xref>). To determine whether enforced expression of <italic>let-7</italic> offered protection from experimental emphysema, <italic>let-7<sup>GOF</sup></italic> and control mice were treated with nCB and then examined for changes in lung pathology and T cell type 17 responses. The <italic>let-7<sup>GOF</sup></italic>mice did not exhibit any signs of lung inflammation or pathologic remodeling at baseline (<xref rid="fig6" ref-type="fig">Figure 6C-D</xref> and data not shown) Histopathologic analysis revealed a comparable degree of lung alveolar distension via morphometric measurements of MLI in nCB-treated <italic>let-7<sup>GOF</sup></italic> mice versus controls suggesting that enforced <italic>let-7</italic> expression is insufficient to protect the lung from emphysema (<xref rid="fig6" ref-type="fig">Figure 6C-D</xref>). On the other hand, evaluation of IL17<sup>+</sup> response and RORγt levels in emphysematous lung T cells demonstrated that, in contrast to control nCB-treated mice, <italic>let-7<sup>GOF</sup></italic> mice exhibited dampened lung Tc17 and Th17 cell populations and were resistant to the induction of RORγt after nCB-exposure (<xref rid="fig6" ref-type="fig">Figure 6F</xref>-<xref rid="fig6" ref-type="fig">6E</xref>). Taken together, our <italic>let-7</italic> LOF and GOF models demonstrate the necessity and sufficiency of <italic>let-7</italic> miRNA to act as a molecular brake to the type 17 T cell response through the direct regulation of RORγt, further our data suggests that nCB- or CS-mediated suppression of this braking mechanism furthers inflammation and exacerbates emphysema severity (<xref rid="fig6" ref-type="fig">Figure 6G</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Enforced <italic>let-7</italic> expression in T cells restrains induction of RORγt and Tc17/Th17 inflammation in lungs of nCB-exposed mice.</title>
<p>(A) Schematic outlining our T cell-inducible <italic>let-7g</italic> mouse model (<italic>let-7<sup>GOF</sup></italic>). (B) Flow analysis of RORγt expression in live, TCRβ<sup>+</sup>CD8<sup>+</sup> or CD4<sup>+</sup> T cells from (B) naïve control and <italic>let-7<sup>GOF</sup></italic> mice in thymus, spleen, and lungs (n=3-5 per group). (C) Control and <italic>let-7<sup>GOF</sup></italic> mice were treated with PBS vehicle or nCB then analyzed. Representative H&amp;E-stained lung sections from PBS- and nCB-exposed mice as indicated on each panel (x20 magnification; scale bars, 50µm) (D) MLI measurements from indicated mice (n=5-6 per group). (E) Flow analysis of lungs gated on live TCRβ<sup>+</sup> CD8<sup>+</sup> or CD4<sup>+</sup> cells for (E) IL-17a<sup>+</sup> population frequency (n=3-4 per group) or (F) RORγt expression by representative flow plot and MFI quantification (n=4-5 per group). (G) Figure model for <italic>let-7</italic>/RORγt axis in emphysema pathogenesis. Data are representative of two or three independent experiments and displayed as mean±SEM using student’s t-test (B) or two-way ANOVA with Tukey’s multiple correction (C,D,E). *p &lt; 0.05, **p &lt; 0.01, ***p &lt;0.001, ****p&lt;0.0001.</p></caption>
<graphic xlink:href="562059v2_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>MiRNA expression-based studies of COPD patients and mice exposed to CS have reported downregulation of <italic>let-7</italic> miRNA expression in lung tissues (<xref ref-type="bibr" rid="c9">Conickx et al., 2017</xref>; <xref ref-type="bibr" rid="c7">Christenson et al., 2013b</xref>; <xref ref-type="bibr" rid="c42">Schembri et al., 2009</xref>). We and others explored the consequence of loss of <italic>let-7</italic> expression/activity with synthetic oligonucleotides, sponges, lentiviral antisense knockdown, or via ectopic delivery of Lin28b (Polikepahad et al., 2010; Viswanathan et al., 2008; Piskounova et al., 2011), but studies pinpointing the role of individual <italic>let-7</italic> clusters as potential drivers of lung inflammation and COPD within T cells remained elusive. In the present study, we established that the <italic>let-7</italic> miRNA family members encoded by the <italic>let-7bc2-</italic> and <italic>let-7afd</italic>-clusters are downregulated in T cells from lungs of emphysema patients and emphysematous mice that were exposed to CS or nCB. Correspondingly, we demonstrated that <italic>in vivo</italic> genetic ablation of <italic>let-7bc2-cluster</italic> further sensitized mice to lung tissue destruction and emphysema upon treatment with nCB or CS. Mechanistically, our studies suggests that <italic>let-7</italic> miRNA prevents the emergence of CD8<sup>+</sup> T cell differentiation into Tc17 cells during emphysema in part, by directly silencing of <italic>Rorc</italic>.</p>
<p>Tc17 cells are vital for defense against viral, fungal, and bacterial infections and they have also been associated with inflammation in various human diseases such as multiple sclerosis, inflammatory bowel disease, and cancer (<xref ref-type="bibr" rid="c21">Huber et al., 2013</xref>; <xref ref-type="bibr" rid="c15">Globig et al., 2022</xref>; <xref ref-type="bibr" rid="c10">Corgnac et al., 2020</xref>). In accordance with the potential pathogenic role of Tc17 cells as drivers of COPD, several studies detected increased cell numbers in airways and tissues of COPD patients as well as lungs of smoke-exposed animal models (<xref ref-type="bibr" rid="c5">Chang et al., 2011</xref>; <xref ref-type="bibr" rid="c55">Zhou et al., 2020</xref>; <xref ref-type="bibr" rid="c12">Duan et al., 2013</xref>). Other researchers also detected increased Tc17 subpopulations in tissues of COPD patients with infectious microbial exacerbations. In our earlier work to define the adaptive T cell immune responses in nCB induced COPD, we predominantly focused on the pathogenic role of Th17 cells, but did not examine Tc17 cells (<xref ref-type="bibr" rid="c53">You et al., 2015</xref>). Here we expand upon our prior observations, revealing that chronic exposure to nCB and elicitation of emphysema mice orchestrates the emergence and accumulation of Tc17 cells which may act in parallel with Th17 cells to promote tissue damage.</p>
<p>Although RORγt has been the subject of intense scrutiny and is subject to extensive transcriptional and post-transcriptional regulatory control, to our knowledge this is the first reported demonstration of miRNA-mediated gene silencing to RORγt. Our data also showed that <italic>in vivo</italic> conditional genetic ablation of individual <italic>let-7</italic> clusters in T cells stimulates a rise in RORγt protein expression in single-positive thymocytes and peripheral CD8<sup>+</sup> and CD4<sup>+</sup> T cells while enforced <italic>let-7</italic> activity leads to partial repression of RORγt in T cells. Despite these alterations in RORγt expression in our <italic>let-7</italic> T cell LOF and GOF mice, the mice did not exhibit spontaneous gross phenotypes in thymus, spleens, or lungs at baseline. This may be due to the subtle and modest expression thresholding of RORγt detected in mice and/or residual <italic>let-7</italic> expression in T cells. On the other hand, and in agreement with our Tc17 and experimental emphysema data, we observed enhanced RORγt expression and IL-17a<sup>+</sup>CD8<sup>+</sup> T cells in lungs of <italic>let-7</italic> LOF mice after treatment with nCB. We corroborated the importance of <italic>let-7</italic> activity in Tc17 differentiation of <italic>ex vivo</italic> cultured CD8<sup>+</sup> T cells, as well as in the direct posttranscriptional control of RORγt, suggesting that this defect, is in part, direct and cell autonomous. Interestingly, even though RORγt was elevated in lung CD4<sup>+</sup> T cells to a similar extent as CD8<sup>+</sup> T cells, the enhanced IL17<sup>+</sup> responses were limited to Tc17 subpopulation in the <italic>let-7bc2<sup>LOF</sup></italic> mice. Although, the <italic>let-7afd<sup>LOF</sup></italic> mice also showed baseline induction of RORγt relative to controls in lung T cells the mice did not exhibit changes in Tc17/Th17 subpopulations (data not shown). Nonetheless, it seems likely that under different cellular contexts, the functions of <italic>let-7-</italic>clusters do not fully overlap in association with differential thresholding of mRNA targets. Indeed, in B cells, the <italic>let-7afd-</italic>cluster is essential for an antigen-specific antibody response, whereas the <italic>let-7bc2-</italic>cluster appears dispensable (<xref ref-type="bibr" rid="c25">Jiang et al., 2018</xref>), iterating that differential physiological role of <italic>let-7</italic> clusters in the immune system and validating an individual cluster approach in dissemination of mechanisms of <italic>let-</italic>7 in T cells. RORγt is a defining transcription factor of the IL-17-secreting subset of immune cells, which also includes γδ17 T cells, NKT17 and type 3 innate lymphoid cells, populations that contribute to COPD pathology (Yanagisawa et al., 2017). A limitation of our study is that we did not examine whether these populations were impacted by nCB-emphysema and/or in the context of <italic>let-7</italic> LOF.</p>
<p>Published studies revealed a protective role of <italic>let-7</italic> family against Th17-driven pathogenic response in EAE attributed in part to direct regulation of <italic>IL-1 receptor 1</italic> and <italic>IL-23 receptor</italic> (<xref ref-type="bibr" rid="c2">Angelou et al., 2020</xref>). Lending some support to these observations, we detected subtle transcript level induction of <italic>Il23r</italic> in <italic>let-7bc2<sup>LOF</sup> in vitro</italic> polarized Tc17 cells (data not shown). However, prior publications on the role of <italic>let-7</italic> in T cells made use of <italic>in vivo Lin28b</italic> transgenic overexpression in immune cells to block maturation and activity of the entire <italic>let-7</italic> miRNA family. Furthermore, <italic>Lin28b</italic> was recently reported to influence transcriptome-wide ribosome occupancy and global miRNA biogenesis (Tan et al., 2019) which could account for differences in scope of <italic>let-7</italic> targets in those studies and ours. Nonetheless, further studies will be required to ascertain whether other targets of <italic>let-7</italic> beyond RORγt synergistically potentiate the <italic>in vivo</italic> Tc17-response and emphysema phenotype in <italic>let7-bc2<sup>LOF</sup></italic>T cells.</p>
<p>Tc17 cells play a major role in microbial infections, providing a potent anti-viral response (<xref ref-type="bibr" rid="c18">Hamada et al., 2009</xref>; <xref ref-type="bibr" rid="c52">Yeh et al., 2010</xref>), while viral infection has been an established factor in COPD exacerbations (<xref ref-type="bibr" rid="c19">Hewitt et al., 2016</xref>; <xref ref-type="bibr" rid="c49">Wedzicha, 2004</xref>). It will be interesting to determine whether loss of <italic>let-7bc2</italic> or <italic>let-7afd</italic>-cluster activity in the T cell compartment contributes to COPD disease susceptibility in the context of viral exposure. Our experiments with <italic>let-7</italic> GOF were partially successful in limiting the emergence of Tc17 and Th17 in nCB-elicited emphysema but it did not protect the lung from alveolar remodeling. Additional, studies will be required to ascertain whether interventions that enhance <italic>let-7</italic> activity are successful in acute models of CS exposure and COPD or in other chronic inflammation diseases associated with dysregulation of RORγt and IL17<sup>+</sup> injury.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Mice</title>
<p>Conditional knockout-ready floxed <italic>let-7bc2</italic> and <italic>let-7afd</italic> mice were generated using CRISPR gene editing in an isogenic C57BL/6 genetic background and were sequence verified for rigor. Mice were PCR genotyped from ear samples with primers flanking loxP sites (Supplementary Table). The <italic>let-7bc2<sup>flox/flox</sup></italic>; <italic>CD4-cre</italic> and <italic>let-7afd<sup>flox/flox</sup></italic>; <italic>CD4-cre</italic> mice were PCR genotyped. The <italic>R26-STOP-rtTA</italic>; <italic>Col1a1-tet0-let-7</italic> (<italic>rtTA-iLet7)</italic> mice were obtained from JAX Jax Stocks 023912 and 05670 and then bred to <italic>CD4-Cre</italic> were PCR genotyped with established JAX primers. Control <italic>rtTA-iLet7</italic> and the <italic>let-7<sup>GOF</sup></italic> mice were fed <italic>ad libitum</italic> with 200mg/kg of doxycycline-containing chow (Bio-Serv S3888) at weaning age. Syngeneic littermates served as controls for all mouse experiments. All mice were bred in the transgenic animal facility at Baylor College of Medicine. All experimental protocols used in this study were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine animal protocol (AN-7389) and followed the National Research Council Guide for the Care and Use of Laboratory Animals.</p>
</sec>
<sec id="s4b">
<title>Human emphysema tissue samples and T cell isolation</title>
<p>Lung tissues were obtained from a total of 28 non-atopic current or former smokers with significant (&gt;20 pack-years, one pack-year equals to smoking one pack of cigarettes per day each year) history of smoking who were recruited into studies from the chest or surgical clinics at Michael E. DeBakey Houston Veterans Affairs Medical Center hospitals (<xref ref-type="bibr" rid="c44">Shan et al., 2009</xref>). Human lung single T cells were prepared from surgical resection and lungs in patients as previously described by selection with biotin-labeled antibodies by autoMACs (Miltenyi Biotec) (Yuan et al., 2020; <xref ref-type="bibr" rid="c16">Grumelli et al., 2004</xref>). Studies were approved by the Institutional Review Board at Baylor College of Medicine and informed consent was obtained from all patients. Emphysema and non-emphysema control patients were diagnosed from CT scans according to the criteria recommended by the National Institutes of Health–World Health Organization workshop summary (<xref ref-type="bibr" rid="c37">Pauwels et al., 2001</xref>).</p>
</sec>
<sec id="s4c">
<title>Human lung transcriptome data</title>
<p>A publicly available RNA-seq dataset from a Korean cohort GSE57148 was selected for the analysis (<xref ref-type="bibr" rid="c28">Kim et al., 2015</xref>). The raw FASTQ files of paired end reads representing the transcriptome of control and cases were retrieved from the GEO database at the National Centre for Biological Information (NCBI) through accession number GSE57148 and analyzed with R package for differential expression.</p>
</sec>
<sec id="s4d">
<title>Cigarette smoke exposure model of pulmonary emphysema</title>
<p>To promote emphysema, mice were exposed to cigarette smoke using our custom designed whole-body inhalation system (<xref ref-type="bibr" rid="c35">Morales-Mantilla et al., 2020</xref>). In total, mice were exposed to four cigarettes (Marlboro 100’s; Philip Morris USA) per day, five days a week, for four months as previously described (<xref ref-type="bibr" rid="c35">Morales-Mantilla et al., 2020</xref>, <xref ref-type="bibr" rid="c46">Shan et al., 2012</xref>).</p>
</sec>
<sec id="s4e">
<title>nCB exposure model of pulmonary emphysema</title>
<p>Nano-sized particulate carbon black was prepared and administered as previously described (<xref ref-type="bibr" rid="c53">You et al., 2015</xref>; <xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>). Dried nCB nanoparticles were resuspended in sterile PBS to a concentration of 10 mg/ml. Fifty µl of reconstituted nCB (0.5 mg) were intranasally delivered to deeply anesthetized mice on a schedule of three times a week for four weeks (total delivered dose of 6 mg). Lung histomorphometry and airway inflammation were assessed four weeks after the final nCB challenge. For histomorphometric analysis, mice lungs were fixed with 10% neutral-buffered formalin solution via a tracheal cannula at 25-cm H2O pressure followed by paraffin embedding and tissue sectioning and stained with hematoxylin and eosin. Mean linear intercept (MLI) measurement of mouse lung morphometry were done as previously described (<xref ref-type="bibr" rid="c45">Shan et al., 2014</xref>; <xref ref-type="bibr" rid="c35">Morales-Mantilla et al., 2020</xref>). Briefly, this was done in a blinded fashion to mice genotypes from ten randomly selected fields of lung parenchyma sections. Paralleled lines were placed on serial lung sections and MLI was calculated by multiplying the length and the number of lines per field, divided by the number of intercepts (<xref ref-type="bibr" rid="c35">Morales-Mantilla et al., 2020</xref>).</p>
<p>BALF was collected by instilling and withdrawing 0.8 ml of sterile PBS twice through the trachea. Total and differential cell counts in the BALF were determined with the standard hemocytometer and HEMA3 staining (Biochemical Sciences Inc, Swedesboro, NJ) using 200 μL of BALF for cytospin slide preparation (<xref ref-type="bibr" rid="c35">Morales-Mantilla et al., 2020</xref>; <xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>).</p>
</sec>
<sec id="s4f">
<title>Cell isolation from murine lung tissue</title>
<p>Mouse lung tissue were cut into 2-mm pieces and digested with collagenase type D (2 mg/ml; Worthington) and deoxyribonuclease (DNase) I (0.04 mg/ml; Roche) for 1 hour in a 37°C incubator. Single-cell suspensions from lung digest, spleen, and thymus were prepared by mincing through 40-μm cell strainers then washing and resuspension in complete RPMI media. Mouse lung and spleen single-cell suspensions were additionally overlaid on Lympholyte M cell separation media (Cedarlane) as indicated in the manufacturer’s protocol to purify lymphocytes. For murine <italic>let-7</italic> expression studies, lung single-cell suspensions were labeled with anti-CD4<sup>+</sup> or anti-CD8<sup>+</sup> magnetic beads and separated by autoMACS (Miltenyi Biotec), or CD4<sup>+</sup>CD8<sup>+</sup> double positive cells purified from thymus single-cell suspensions by flow-cytometric sorting on FACS Aria (BD Biosciences).</p>
</sec>
<sec id="s4g">
<title><italic>In vitro</italic> polarization of CD8<sup>+</sup> T cells</title>
<p>CD8<sup>+</sup> naïve T cells were isolated from spleen using Mojosort Mouse CD8 Naïve T cell isolation Kit (Biolegend) and adjusted to a concentration of 1.0x10<sup>6</sup> cells/mL. Purified cells were activated with plate-bound anti-CD3 (1.5µg/mL) and complete RPMI media containing anti-CD28 (1.5µg/mL) and β-mercaptoethanol (50nM) for Tc0 polarization, or further supplemented with Tc1 [IL-2 (10ng/mL)] or Tc17 [TGFβ (2ng/mL), IL-6 (20ng/mL), anti-IFNγ (10µg/mL), IL-23 (20ng/mL), and IL-1β (5ng/mL)] polarization conditions for 72 hours (Flores-Santibáñez et al., 2018).</p>
</sec>
<sec id="s4h">
<title>ELISA</title>
<p>Supernatant was collected from <italic>in vitro</italic> polarized murine CD8<sup>+</sup> T cells and centrifuged to remove cellular debris. Cytokine levels of IL-17a and IFNγ were quantified from collected supernatant using Mouse IL-17a Uncoated ELISA and Mouse IFN gamma Uncoated ELISA (Invitrogen) Kits, respectively, per the manufacturer’s instructions with colorimetric analysis by the Varioskan LUX microplate reader (ThermoFisher).</p>
</sec>
<sec id="s4i">
<title>Flow cytometric analysis</title>
<p>Cells used for <italic>in vitro</italic> or <italic>in vivo</italic> cytokine analysis were stimulated with PMA (20ng/mL; Sigma Aldrich), Ionomycin (1µg/mL; Sigma Aldrich), and Brefeldin A (2µg/mL; Sigma Aldrich) for 4 hours prior to flow staining (<xref ref-type="bibr" rid="c33">Lu et al., 2015</xref>). For intracellular staining, cells were fixed and permeabilized using the Mouse FOXP3 Buffer Set (BD) per the manufacturer’s protocol. The fluorophore-conjugated antibodies used in this study were as follows: Live/Dead Fix Blue (Invitrogen), CD3 PerCPCy5.5 (Biolegend), TCRb PE/Cy7 (Biolegend), CD4 PB (Biolegend), CD4 AF700 (Biolegend), CD8 BV650 (Biolegend), CD25 BV421 (Biolegend), FOXP3 AF488 (Biolegend), ROR gamma T PE (Invitrogen), TCF1 AF647 (Cell Signaling Technologies), TCF1 PE (Biolegend), IFNγ AF647 (Biolegend), IL17a FITC (Biolegend), IL17a PE (ebioscience), PD1 BUV737 (BD), TIM3 AF647 (R&amp;D). Samples were analyzed using BD LSR II flow cytometer (BD Biosciences) and FlowJo software (TreeStar),</p>
</sec>
<sec id="s4j">
<title>RNA Isolation and Quantitative RT-PCR</title>
<p>RNA was isolated using miRNeasy (Qiagen) or RNeasy Mini Kit (Qiagen) in conjunction with the RNase-Free DNase (Qiagen) according to the manufacturer’s instructions. cDNA of miRNAs and mRNAs were synthesized using TaqMan Advanced miRNA cDNA Synthesis Kit (ThermoFisher) and High-Capacity cDNA Reverse Transcription Kit Real-Time PCR system (Applied Biosystems). 18S and snoRNA-202 were used to normalize mRNA and miRNA expression respectively. Quantitative RT-PCR data were acquired on 7500 Real-Time PCR System or StepOne Real-Time PCR System (Applied Biosystems) with the following TaqMan probes: <italic>hsa-let-7a</italic> [000377], <italic>hsa-let-7b</italic> [000378], <italic>hsa-let-7d</italic> [002283], <italic>hsa-let-7f</italic> [000382], <italic>pri-miR-let7a</italic> [Mm03306744_pri], <italic>pri-miR-let7d</italic> [Mm03306666_pri], <italic>pri-miR-let7b</italic> [Mm03306756_pri], <italic>Mmp9</italic> [Mm00442991], <italic>Mmp12</italic> [Mm00500554].</p>
</sec>
<sec id="s4k">
<title>Luciferase reporter assays</title>
<p>Genomic fragment containing the murine <italic>Rorc</italic> 3’UTR was cloned into psiCHECK2 luciferase reporter plasmid (Promega). This construct was also used to generate the <italic>let-7</italic> ʻseed’ deletion mutant derivative using the QuikChange Multi Site Mutagenesis Kit (catalog 200514-5, Stratagene). 3T3 mouse embryonic fibroblasts (MEFs) were transfected using Oligofectamine (Invitrogen) with 100 ng of psiCheck-2 plasmid containing wild-type or mutant 3’UTR, along with the miRNA control or <italic>let-7b</italic> duplex (Dharmacon) at a final concentration of 6 nM (Gurha et al., 2012). Reporter activity was detected with the Dual-Luciferase Reporter Assay System (Promega).</p>
</sec>
<sec id="s4l">
<title>Statistical analysis</title>
<p>Statistical analyses were performed using GraphPad Prism 10.0.1 software. Statistical comparison between groups was performed using the unpaired Student’s t-test, two-way analysis of variance (ANOVA) with Tukey’s or Sidak’s correction, and Mann-Whitney Test when indicated. A P-value less than 0.05 was considered statistically significant; ns indicates not significant. Statistical significance values were set as *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, and ****p &lt; 0.0001. Data are presented as means ± SEM. P-value and sample sizes (n) are indicated in the figure legends.</p>
</sec>
</sec>
<sec id="d1e1996" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e2099">
<label>Supplemental Figure 1</label>
<media xlink:href="supplements/562059_file02.pdf"/>
</supplementary-material>
<supplementary-material id="d1e2106">
<label>Supplemental Table 1</label>
<media xlink:href="supplements/562059_file03.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<sec id="s5">
<title>Competing interest statement</title>
<p>The authors declare no competing interests.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Jason Heaney and Denise Lanza at BCM Genetically Engineered Rodents Core (funded in part by NIH P30 CA125123); Patricia Castro at Tissue Acquisition and Pathology Core (funded in part by P30 CA125123); and Joel M. Sederstrom at the BCM and Cell Sorting Core with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672) and NIH (CA125123 and RR024574). This work was supported by grants from the NHLBI (R01HL140398 to AR), the Gilson Longenbaugh Foundation (to A.R.), and NIEHS (T32 ES027801 to PE).</p>
</ack>
<sec id="s6">
<title>Author contributions</title>
<p>P.E., X.H., D.B.C, F.K., and A.R. conceptualized experiments and interpreted results. P.E., X.H., M.J.S., H.T., M.A.P., and S.L.L. acquired the data, M.J.R. provided bioinformatics analyses. P.E. and A.R. wrote the manuscript.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Agarwal</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Bell</surname>, <given-names>G. W.</given-names></string-name>, <string-name><surname>Nam</surname>, <given-names>J.-W.</given-names></string-name>, &amp; <string-name><surname>Bartel</surname>, <given-names>D. P</given-names></string-name>. (<year>2015</year>). <article-title>Predicting effective microRNA target sites in mammalian mRNAs</article-title>. <source>eLife</source>, <volume>4</volume>, <fpage>e05005</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.05005</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Angelou</surname>, <given-names>C. C.</given-names></string-name>, <string-name><surname>Wells</surname>, <given-names>A. C.</given-names></string-name>, <string-name><surname>Vijayaraghavan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Dougan</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Lawlor</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Iverson</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lazarevic</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Kimura</surname>, <given-names>M. Y.</given-names></string-name>, <string-name><surname>Peyton</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Minter</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Osborne</surname>, <given-names>B. A.</given-names></string-name>, <string-name><surname>Pobezinskaya</surname>, <given-names>E. L.</given-names></string-name>, &amp; <string-name><surname>Pobezinsky</surname>, <given-names>L. A</given-names></string-name>. (<year>2020</year>). <article-title>Differentiation of Pathogenic Th17 Cells Is Negatively Regulated by Let-7 MicroRNAs in a Mouse Model of Multiple Sclerosis</article-title>. <source>Frontiers in Immunology</source>, <volume>10</volume>, <fpage>3125</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.03125</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Barnes</surname>, <given-names>P. J</given-names></string-name>. (<year>2016</year>). <article-title>Inflammatory mechanisms in patients with chronic obstructive pulmonary disease</article-title>. <source>Journal of Allergy and Clinical Immunology</source>, <volume>138</volume>(<issue>1</issue>), <fpage>16</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2016.05.011</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Beringer</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Noack</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Miossec</surname>, <given-names>P</given-names></string-name>. (<year>2016</year>). <article-title>IL-17 in Chronic Inflammation: From Discovery to Targeting</article-title>. <source>Trends in Molecular Medicine</source>, <volume>22</volume>(<issue>3</issue>), <fpage>230</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2016.01.001</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Chang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Nadigel</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Boulais</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bourbeau</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Maltais</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Eidelman</surname>, <given-names>D. H.</given-names></string-name>, &amp; <string-name><surname>Hamid</surname>, <given-names>Q</given-names></string-name>. (<year>2011</year>). <article-title>CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease</article-title>. <source>Respiratory Research</source>, <volume>12</volume>(<issue>1</issue>), <fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/1465-9921-12-43</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Christenson</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Brandsma</surname>, <given-names>C.-A.</given-names></string-name>, <string-name><surname>Campbell</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Pechkovsky</surname>, <given-names>D. V.</given-names></string-name>, <string-name><surname>Hogg</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Timens</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Postma</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Lenburg</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Spira</surname>, <given-names>A</given-names></string-name>. (<year>2013a</year>). <article-title>miR-638 regulates gene expression networks associated with emphysematous lung destruction</article-title>. <source>Genome Medicine</source>, <volume>5</volume>(<issue>12</issue>), <fpage>114</fpage>. <pub-id pub-id-type="doi">10.1186/gm519</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Christenson</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Brandsma</surname>, <given-names>C.-A.</given-names></string-name>, <string-name><surname>Campbell</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Knight</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Pechkovsky</surname>, <given-names>D. V.</given-names></string-name>, <string-name><surname>Hogg</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Timens</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Postma</surname>, <given-names>D. S.</given-names></string-name>, <string-name><surname>Lenburg</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Spira</surname>, <given-names>A</given-names></string-name>. (<year>2013b</year>). <article-title>miR-638 regulates gene expression networks associated with emphysematous lung destruction</article-title>. <source>Genome Medicine</source>, <volume>5</volume>(<issue>12</issue>), <fpage>114</fpage>. <pub-id pub-id-type="doi">10.1186/gm519</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Chu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhong</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lao</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>Z.</given-names></string-name>, &amp; <string-name><surname>Bai</surname>, <given-names>J</given-names></string-name>. (<year>2011</year>). <article-title>The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients</article-title>. <source>International Immunopharmacology</source>, <volume>11</volume>(<issue>11</issue>), <fpage>1780</fpage>–<lpage>1788</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2011.06.010</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Conickx</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Avila Cobos</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>van den Berge</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Faiz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Timens</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Hiemstra</surname>, <given-names>P. S.</given-names></string-name>, <string-name><surname>Joos</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Brusselle</surname>, <given-names>G. G.</given-names></string-name>, <string-name><surname>Mestdagh</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Bracke</surname>, <given-names>K. R.</given-names></string-name> (<year>2017</year>). <article-title>microRNA profiling in lung tissue and bronchoalveolar lavage of cigarette smoke-exposed mice and in COPD patients: A translational approach</article-title>. <source>Scientific Reports</source>, <volume>7</volume>(<fpage>1</fpage>), Article 1. <pub-id pub-id-type="doi">10.1038/s41598-017-13265-8</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Corgnac</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Malenica</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Mezquita</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Auclin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Voilin</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Kacher</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Halse</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Grynszpan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Signolle</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Dayris</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Leclerc</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Droin</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>de Montpréville</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Mercier</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Validire</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Scoazec</surname>, <given-names>J.-Y.</given-names></string-name>, <string-name><surname>Massard</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chouaib</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Planchard</surname>, <given-names>D</given-names></string-name>., … <string-name><surname>Mami-Chouaib</surname>, <given-names>F</given-names></string-name>. (<year>2020</year>). <article-title>CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17</article-title>. <source>Cell Reports Medicine</source>, <volume>1</volume>(<issue>7</issue>), <fpage>100127</fpage>. <pub-id pub-id-type="doi">10.1016/j.xcrm.2020.100127</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Duan</surname>, <given-names>M.-C.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>H.-J.</given-names></string-name>, <string-name><surname>Zhong</surname>, <given-names>X.-N.</given-names></string-name>, &amp; <string-name><surname>Huang</surname>, <given-names>Y</given-names></string-name>. (<year>2013</year>). <article-title>Persistence of Th17/Tc17 Cell Expression upon Smoking Cessation in Mice with Cigarette Smoke-Induced Emphysema</article-title>. <source>Journal of Immunology Research</source>, <volume>2013</volume>, <fpage>e350727</fpage>. <pub-id pub-id-type="doi">10.1155/2013/350727</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Duan</surname>, <given-names>M.-C.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.-Q.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>G.-N.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>H.-J.</given-names></string-name>, &amp; <string-name><surname>Liang</surname>, <given-names>Y</given-names></string-name>. (<year>2016</year>). <article-title>Infiltration of IL-17-Producing T Cells and Treg Cells in a Mouse Model of Smoke-Induced Emphysema</article-title>. <source>Inflammation</source>, <volume>39</volume>(<issue>4</issue>), <fpage>1334</fpage>–<lpage>1344</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-016-0365-8</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="web"><collab>Findings from the Global Burden of Disease Study 2017</collab>. (<year>2019</year>, January 4). <source>Institute for Health Metrics and Evaluation</source>. <ext-link ext-link-type="uri" xlink:href="https://www.healthdata.org/policy-report/findings-global-burden-disease-study-2017">https://www.healthdata.org/policy-report/findings-global-burden-disease-study-2017</ext-link></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Globig</surname>, <given-names>A.-M.</given-names></string-name>, <string-name><surname>Hipp</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Otto-Mora</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Heeg</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mayer</surname>, <given-names>L. S.</given-names></string-name>, <string-name><surname>Ehl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Schwacha</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Bewtra</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tomov</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Thimme</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hasselblatt</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Bengsch</surname>, <given-names>B</given-names></string-name>. (<year>2022</year>). <article-title>High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature</article-title>. <source>Nature Communications</source>, <volume>13</volume>(<fpage>1</fpage>), Article 1. <pub-id pub-id-type="doi">10.1038/s41467-022-31229-z</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Grumelli</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.-Z.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Green</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Huh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Hacken</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Espada</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bag</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lewis</surname>, <given-names>D. E.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2004</year>). <article-title>An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema</article-title>. <source>PLOS Medicine</source>, <volume>1</volume>(<issue>1</issue>), <fpage>e8</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0010008</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Guan</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Mrelashvili</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Hao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Singh</surname>, <given-names>N. P.</given-names></string-name>, <string-name><surname>Singh</surname>, <given-names>U. P.</given-names></string-name>, <string-name><surname>Nagarkatti</surname>, <given-names>P. S.</given-names></string-name>, &amp; <string-name><surname>Nagarkatti</surname>, <given-names>M</given-names></string-name>. (<year>2013</year>). <article-title>MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis</article-title>. <source>European Journal of Immunology</source>, <volume>43</volume>(<issue>1</issue>), <fpage>104</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201242702</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Hamada</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Garcia-Hernandez</surname>, <given-names>M. de la L.</given-names></string-name>, <string-name><surname>Reome</surname>, <given-names>J. B.</given-names></string-name>, <string-name><surname>Misra</surname>, <given-names>S. K.</given-names></string-name>, <string-name><surname>Strutt</surname>, <given-names>T. M.</given-names></string-name>, <string-name><surname>McKinstry</surname>, <given-names>K. K.</given-names></string-name>, <string-name><surname>Cooper</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Swain</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name><surname>Dutton</surname>, <given-names>R. W</given-names></string-name>. (<year>2009</year>). <article-title>Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge1</article-title>. <source>The Journal of Immunology</source>, <volume>182</volume>(<issue>6</issue>), <fpage>3469</fpage>–<lpage>3481</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0801814</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Hewitt</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Farne</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ritchie</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Luke</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Johnston</surname>, <given-names>S. L.</given-names></string-name>, &amp; <string-name><surname>Mallia</surname>, <given-names>P</given-names></string-name>. (<year>2016</year>). <article-title>The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma</article-title>. <source>Therapeutic Advances in Respiratory Disease</source>, <volume>10</volume>(<issue>2</issue>), <fpage>158</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1177/1753465815618113</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Hoenderdos</surname>, <given-names>K.</given-names></string-name>, &amp; <string-name><surname>Condliffe</surname>, <given-names>A</given-names></string-name>. (<year>2013</year>). <article-title>The Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or Too Much, Too Soon?</article-title> <source>American Journal of Respiratory Cell and Molecular Biology</source>, <volume>48</volume>(<issue>5</issue>), <fpage>531</fpage>–<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2012-0492TR</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Huber</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Heink</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pagenstecher</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Reinhard</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ritter</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Visekruna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Guralnik</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bollig</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jeltsch</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Heinemann</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wittmann</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Buch</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Costa</surname>, <given-names>O. P. da</given-names></string-name>, <string-name><surname>Brüstle</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Brenner</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Mak</surname>, <given-names>T. W.</given-names></string-name>, <string-name><surname>Mittrücker</surname>, <given-names>H.-W.</given-names></string-name>, <string-name><surname>Tackenberg</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Kamradt</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Lohoff</surname>, <given-names>M</given-names></string-name>. (<year>2013</year>). <article-title>IL-17A secretion by CD8<sup>+</sup> T cells supports Th17-mediated autoimmune encephalomyelitis</article-title>. <source>The Journal of Clinical Investigation</source>, <volume>123</volume>(<issue>1</issue>), <fpage>247</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1172/JCI63681</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Ivanov</surname>, <given-names>I. I.</given-names></string-name>, <string-name><surname>McKenzie</surname>, <given-names>B. S.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Tadokoro</surname>, <given-names>C. E.</given-names></string-name>, <string-name><surname>Lepelley</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lafaille</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Cua</surname>, <given-names>D. J.</given-names></string-name>, &amp; <string-name><surname>Littman</surname>, <given-names>D. R</given-names></string-name>. (<year>2006</year>). <article-title>The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells</article-title>. <source>Cell</source>, <volume>126</volume>(<issue>6</issue>), <fpage>1121</fpage>– <lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2006.07.035</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Ivanov</surname>, <given-names>I. I.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Littman</surname>, <given-names>D. R</given-names></string-name>. (<year>2007</year>). <article-title>Transcriptional Regulation of Th17 Cell Differentiation</article-title>. <source>Seminars in Immunology</source>, <volume>19</volume>(<issue>6</issue>), <fpage>409</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2007.10.011</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Izzotti</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Calin</surname>, <given-names>G. A.</given-names></string-name>, <string-name><surname>Arrigo</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Steele</surname>, <given-names>V. E.</given-names></string-name>, <string-name><surname>Croce</surname>, <given-names>C. M.</given-names></string-name>, &amp; <string-name><surname>De Flora</surname>, <given-names>S.</given-names></string-name> (<year>2009</year>). <article-title>Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke</article-title>. <source>The FASEB Journal</source>, <volume>23</volume>(<issue>3</issue>), <fpage>806</fpage>–<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-121384</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Jiang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S. E.</given-names></string-name>, &amp; <string-name><surname>Baltimore</surname>, <given-names>D</given-names></string-name>. (<year>2018</year>). <article-title>Let-7 Suppresses B Cell Activation through Restricting the Availability of Necessary Nutrients</article-title>. <source>Cell Metabolism</source>, <volume>27</volume>(<issue>2</issue>), <fpage>393</fpage>–<lpage>403</lpage>.e4. <pub-id pub-id-type="doi">10.1016/j.cmet.2017.12.007</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Jin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>M.-Q.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>J.-C.</given-names></string-name>, <string-name><surname>Xiong</surname>, <given-names>X.-Z.</given-names></string-name>, &amp; <string-name><surname>Xin</surname>, <given-names>J.-B</given-names></string-name>. (<year>2014</year>). <article-title>Treg/IL-17 Ratio and Treg Differentiation in Patients with COPD</article-title>. <source>PLOS ONE</source>, <volume>9</volume>(<issue>10</issue>), <fpage>e111044</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0111044</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Kheradmand</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Corry</surname>, <given-names>D. B</given-names></string-name>. (<year>2012</year>). <article-title>Autoimmunity in chronic obstructive pulmonary disease: Clinical and experimental evidence</article-title>. <source>Expert Review of Clinical Immunology</source>, <volume>8</volume>(<issue>3</issue>), <fpage>285</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1586/eci.12.7</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>W. J.</given-names></string-name>, <string-name><surname>Lim</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.-D.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J. H.</given-names></string-name>, &amp; <string-name><surname>Oh</surname>, <given-names>Y.-M</given-names></string-name>. (<year>2015</year>). <article-title>Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects</article-title>. <source>International Journal of Genomics</source>, <volume>2015</volume>, <fpage>206937</fpage>. <pub-id pub-id-type="doi">10.1155/2015/206937</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Laniado-Laborín</surname>, <given-names>R</given-names></string-name>. (<year>2009</year>). <article-title>Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century</article-title>. <source>International Journal of Environmental Research and Public Health</source>, <volume>6</volume>(<issue>1</issue>), Article 1. <pub-id pub-id-type="doi">10.3390/ijerph6010209</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>P. P.</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>Beard</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Jessup</surname>, <given-names>H. K.</given-names></string-name>, <string-name><surname>Lehar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Makar</surname>, <given-names>K. W.</given-names></string-name>, <string-name><surname>Pérez-Melgosa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sweetser</surname>, <given-names>M. T.</given-names></string-name>, <string-name><surname>Schlissel</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Nguyen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cherry</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>J. H.</given-names></string-name>, <string-name><surname>Tucker</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Weaver</surname>, <given-names>W. M.</given-names></string-name>, <string-name><surname>Kelso</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jaenisch</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Wilson</surname>, <given-names>C. B</given-names></string-name>. (<year>2001</year>). <article-title>A Critical Role for Dnmt1 and DNA Methylation in T Cell Development, Function, and Survival</article-title>. <source>Immunity</source>, <volume>15</volume>(<issue>5</issue>), <fpage>763</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-7613(01)00227-8</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>S.-H.</given-names></string-name>, <string-name><surname>Goswami</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Grudo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.-Z.</given-names></string-name>, <string-name><surname>Bandi</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Goodnight-White</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Green</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hacken-Bitar</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bakaeen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Coxson</surname>, <given-names>H. O.</given-names></string-name>, <string-name><surname>Cogswell</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Storness-Bliss</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2007</year>). <article-title>Antielastin autoimmunity in tobacco smoking-induced emphysema</article-title>. <source>Nature Medicine</source>, <volume>13</volume>(<issue>5</issue>), <fpage>567</fpage>–<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1038/nm1583</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xiao</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Zhang</surname>, <given-names>Y</given-names></string-name>. (<year>2015</year>). <article-title>Disruption of Th17/Treg Balance in the Sputum of Patients With Chronic Obstructive Pulmonary Disease</article-title>. <source>The American Journal of the Medical Sciences</source>, <volume>349</volume>(<issue>5</issue>), <fpage>392</fpage>–<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1097/MAJ.0000000000000447</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Lu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>You</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Samuel</surname>, <given-names>E. L. G.</given-names></string-name>, <string-name><surname>Marcano</surname>, <given-names>D. C.</given-names></string-name>, <string-name><surname>Sikkema</surname>, <given-names>W. K. A.</given-names></string-name>, <string-name><surname>Tour</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Rodriguez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kheradmand</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name><surname>Corry</surname>, <given-names>D. B</given-names></string-name>. (<year>2015</year>). <article-title>MicroRNA-22 Inhibits Histone Deacetylase 4 to Promote T Helper-17 Cell-Dependent Emphysema</article-title>. <source>Nature Immunology</source>, <volume>16</volume>(<issue>11</issue>), <fpage>1185</fpage>–<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3292</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Mai</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Virtue</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Maley</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tran</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Meng</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pansuria</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jiang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Yang</surname>, <given-names>X.-F</given-names></string-name>. (<year>2012</year>). <article-title>MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors</article-title>. <source>Frontiers in Bioscience (Elite Edition</source><italic>)</italic>, <volume>4</volume>, <fpage>1478</fpage>–<lpage>1495</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Morales-Mantilla</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Erice</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Porter</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Figueroa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Chandra</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>King</surname>, <given-names>K. Y.</given-names></string-name>, <string-name><surname>Kheradmand</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name><surname>Rodríguez</surname>, <given-names>A</given-names></string-name>. (<year>2020</year>). <article-title>Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System</article-title>. <source>JoVE (Journal of Visualized Experiments</source><italic>)</italic>, <volume>164</volume>, <fpage>e61793</fpage>. <pub-id pub-id-type="doi">10.3791/61793</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Newcomb</surname>, <given-names>D. C.</given-names></string-name>, <string-name><surname>Cephus</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>Boswell</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Fahrenholz</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Langley</surname>, <given-names>E. W.</given-names></string-name>, <string-name><surname>Feldman</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Dulek</surname>, <given-names>D. E.</given-names></string-name>, <string-name><surname>Goleniewska</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Woodward</surname>, <given-names>K. B.</given-names></string-name>, <string-name><surname>Sevin</surname>, <given-names>C. M.</given-names></string-name>, <string-name><surname>Hamilton</surname>, <given-names>R. G.</given-names></string-name>, <string-name><surname>Kolls</surname>, <given-names>J. K.</given-names></string-name>, &amp; <string-name><surname>Peebles</surname>, <given-names>R. S</given-names></string-name>. (<year>2015</year>). <article-title>Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma</article-title>. <source>Journal of Allergy and Clinical Immunology</source>, <volume>136</volume>(<issue>4</issue>), <fpage>1025</fpage>–<lpage>1034</lpage>.e11. <pub-id pub-id-type="doi">10.1016/j.jaci.2015.05.046</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Pauwels</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Buist</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Calverley</surname>, <given-names>P. M. A.</given-names></string-name>, <string-name><surname>Jenkins</surname>, <given-names>C. R.</given-names></string-name>, &amp; <string-name><surname>Hurd</surname>, <given-names>S. S</given-names></string-name>. (<year>2001</year>). <article-title>Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease</article-title>. <source>American Journal of Respiratory and Critical Care Medicine</source>, <volume>163</volume>(<issue>5</issue>), <fpage>1256</fpage>–<lpage>1276</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.163.5.2101039</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Peleman</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Rytila</surname>, <given-names>P. H.</given-names></string-name>, <string-name><surname>Kips</surname>, <given-names>J. C.</given-names></string-name>, <string-name><surname>Joos</surname>, <given-names>G. F.</given-names></string-name>, &amp; <string-name><surname>Pauwels</surname>, <given-names>R. A</given-names></string-name>. (<year>1999</year>). <article-title>The cellular composition of induced sputum in chronic obstructive pulmonary disease</article-title>. <source>European Respiratory Journal</source>, <volume>13</volume>(<issue>4</issue>), <fpage>839</fpage>–<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1034/j.1399-3003.1999.13d24.x</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Pottelberge</surname>, <given-names>G. R. V.</given-names></string-name>, <string-name><surname>Mestdagh</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Bracke</surname>, <given-names>K. R.</given-names></string-name>, <string-name><surname>Thas</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Durme</surname>, <given-names>Y. M. T. A. van</given-names></string-name>, <string-name><surname>Joos</surname>, <given-names>G. F.</given-names></string-name>, <string-name><surname>Vandesompele</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Brusselle</surname>, <given-names>G. G</given-names></string-name>. (<year>2011</year>). <article-title>MicroRNA Expression in Induced Sputum of Smokers and Patients with Chronic Obstructive Pulmonary Disease</article-title>. <source>American Journal of Respiratory and Critical Care Medicine</source>, <volume>183</volume>(<issue>7</issue>), <fpage>898</fpage>–<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201002-0304OC</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><collab>Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017.</collab> (<year>2020</year>). <source>The Lancet. Respiratory Medicine</source>, <volume>8</volume>(<issue>6</issue>), <fpage>585</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(20)30105-3</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Rodriguez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Griffiths-Jones</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ashurst</surname>, <given-names>J. L.</given-names></string-name>, &amp; <string-name><surname>Bradley</surname>, <given-names>A</given-names></string-name>. (<year>2004</year>). <article-title>Identification of Mammalian microRNA Host Genes and Transcription Units</article-title>. <source>Genome Research</source>, <volume>14</volume>(<issue>10a</issue>), <fpage>1902</fpage>–<lpage>1910</lpage>. <pub-id pub-id-type="doi">10.1101/gr.2722704</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Schembri</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Sridhar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Perdomo</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gustafson</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ergun</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Bowers</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vaziri</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ott</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Sensinger</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Collins</surname>, <given-names>J. J.</given-names></string-name>, <string-name><surname>Brody</surname>, <given-names>J. S.</given-names></string-name>, <string-name><surname>Getts</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lenburg</surname>, <given-names>M. E.</given-names></string-name>, &amp; <string-name><surname>Spira</surname>, <given-names>A</given-names></string-name>. (<year>2009</year>). <article-title>MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>106</volume>(<issue>7</issue>), <fpage>2319</fpage>–<lpage>2324</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0806383106</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Senior</surname>, <given-names>R. M.</given-names></string-name>, &amp; <string-name><surname>Anthonisen</surname>, <given-names>N. R</given-names></string-name>. (<year>1998</year>). <article-title>Chronic Obstructive Pulmonary Disease (COPD)</article-title>. <source>American Journal of Respiratory and Critical Care Medicine</source>, <volume>157</volume>(<issue>4</issue>), <fpage>S139</fpage>–<lpage>S147</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.157.4.nhlbi-12</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>H.-F.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Roberts</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Green</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hacken-Bitar</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Huh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bakaeen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Coxson</surname>, <given-names>H. O.</given-names></string-name>, <string-name><surname>Storness-Bliss</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ramchandani</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.-H.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2009</year>). <article-title>Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema</article-title>. <source>Science Translational Medicine</source>, <volume>1</volume>(<issue>4</issue>), <fpage>4r</fpage>a<lpage>10</lpage>-4ra10. <pub-id pub-id-type="doi">10.1126/scitranlsmed.3000154</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>You</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Frazier</surname>, <given-names>M. V.</given-names></string-name>, <string-name><surname>Porter</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Seryshev</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hong</surname>, <given-names>J.-S.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Hilsenbeck</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Whitehead</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zarinkamar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Perusich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2014</year>). <article-title>Agonistic induction of PPARγ reverses cigarette smoke–induced emphysema</article-title>. <source>The Journal of Clinical Investigation</source>, <volume>124</volume>(<issue>3</issue>), <fpage>1371</fpage>–<lpage>1381</lpage>. <pub-id pub-id-type="doi">10.1172/JCI70587</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Roberts</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zarinkamar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Seryshev</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Hilsenbeck</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>S.-H.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2012</year>). <article-title>Cigarette Smoke Induction of Osteopontin (SPP1) Mediates TH17 Inflammation in Human and Experimental Emphysema</article-title>. <source>Science Translational Medicine</source>, <volume>4</volume>(<issue>117</issue>), <fpage>117r</fpage>a<lpage>9</lpage>-117ra9. <pub-id pub-id-type="doi">10.1126/scitranslmed.3003041</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Shi</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Petrie</surname>, <given-names>H. T</given-names></string-name>. (<year>2012</year>). <article-title>Activation Kinetics and Off-Target Effects of Thymus-Initiated Cre Transgenes</article-title>. <source>PLoS ONE</source>, <volume>7</volume>(<issue>10</issue>), <fpage>e46590</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046590</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Veldhoen</surname>, <given-names>M</given-names></string-name>. (<year>2017</year>). <article-title>Interleukin 17 is a chief orchestrator of immunity</article-title>. <source>Nature Immunology</source>, <volume>18</volume>(<fpage>6</fpage>), Article 6. <pub-id pub-id-type="doi">10.1038/ni.3742</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Wedzicha</surname>, <given-names>J. A</given-names></string-name>. (<year>2004</year>). <article-title>Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease</article-title>. <source>Proceedings of the American Thoracic Society</source>, <volume>1</volume>(<issue>2</issue>), <fpage>115</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1513/pats.2306030</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Williams</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Todd</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name><surname>Fairclough</surname>, <given-names>L. C</given-names></string-name>. (<year>2021</year>). <article-title>The role of CD8 + T lymphocytes in chronic obstructive pulmonary disease: A systematic review</article-title>. <source>Inflammation Research</source>, <volume>70</volume>(<issue>1</issue>), <fpage>11</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-020-01408-z</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hesselbacher</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tsai</surname>, <given-names>C.-L.</given-names></string-name>, <string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Spitz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Scheurer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Roberts</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Perusich</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zarinkamar</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Coxson</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Krowchuk</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2012</year>). <article-title>Autoreactive T Cells in Human Smokers is Predictive of Clinical Outcome</article-title>. <source>Frontiers in Immunology</source>, <volume>3</volume>. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2012.00267">https://www.frontiersin.org/articles/10.3389/fimmu.2012.00267</ext-link></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Yeh</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Glosson</surname>, <given-names>N. L.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Guindon</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McKinley</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Hamada</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Dutton</surname>, <given-names>R. W.</given-names></string-name>, <string-name><surname>Shrikant</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Brutkiewicz</surname>, <given-names>R. R.</given-names></string-name>, <string-name><surname>Blum</surname>, <given-names>J. S.</given-names></string-name>, &amp; <string-name><surname>Kaplan</surname>, <given-names>M. H</given-names></string-name>. (<year>2010</year>). <article-title>Tc17 Cells Are Capable of Mediating Immunity to Vaccinia Virus by Acquisition of a Cytotoxic Phenotype</article-title>. <source>The Journal of Immunology</source>, <volume>185</volume>(<issue>4</issue>), <fpage>2089</fpage>–<lpage>2098</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1000818</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>You</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Shan</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Berlin</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Samuel</surname>, <given-names>E. L.</given-names></string-name>, <string-name><surname>Marcano</surname>, <given-names>D. C.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Sikkema</surname>, <given-names>W. K.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Hendrix</surname>, <given-names>A. Y.</given-names></string-name>, <string-name><surname>Tour</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Corry</surname>, <given-names>D. B.</given-names></string-name>, &amp; <string-name><surname>Kheradmand</surname>, <given-names>F</given-names></string-name>. (<year>2015</year>). <article-title>Nanoparticulate carbon black in cigarette smoke induces DNA cleavage and Th17-mediated emphysema</article-title>. <source>eLife</source>, <volume>4</volume>, <fpage>e09623</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.09623</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Qiu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>Y.</given-names></string-name>, &amp; <string-name><surname>Zhong</surname>, <given-names>X</given-names></string-name>. (<year>2019</year>). <article-title>Rapamycin attenuates Tc1 and Tc17 cell responses in cigarette smoke-induced emphysema in mice</article-title>. <source>Inflammation Research</source>, <volume>68</volume>(<issue>11</issue>), <fpage>957</fpage>–<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-019-01278-0</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname>, <given-names>J.-S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.-Y.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>X.-C.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>H.-P.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.-F.</given-names></string-name>, <string-name><surname>Lai</surname>, <given-names>T.-W.</given-names></string-name>, <string-name><surname>Di</surname>, <given-names>C.-H.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>L.-L.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xuan</surname>, <given-names>N.-X.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.-P.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>H.-Q.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>F.-G.</given-names></string-name>, <string-name><surname>Hua</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, … <string-name><surname>Shen</surname>, <given-names>H.-H</given-names></string-name>. (<year>2020</year>). <article-title>Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice</article-title>. <source>European Respiratory Journal</source>, <volume>56</volume>(<fpage>3</fpage>). <pub-id pub-id-type="doi">10.1183/13993003.00404-2020</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Shyh-Chang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Segrè</surname>, <given-names>A. V.</given-names></string-name>, <string-name><surname>Shinoda</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>S. P.</given-names></string-name>, <string-name><surname>Einhorn</surname>, <given-names>W. S.</given-names></string-name>, <string-name><surname>Takeuchi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Engreitz</surname>, <given-names>J. M.</given-names></string-name>, <string-name><surname>Hagan</surname>, <given-names>J. P.</given-names></string-name>, <string-name><surname>Kharas</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Urbach</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Thornton</surname>, <given-names>J. E.</given-names></string-name>, <string-name><surname>Triboulet</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gregory</surname>, <given-names>R. I.</given-names></string-name>, <string-name><surname>Altshuler</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Daley</surname>, <given-names>G. Q</given-names></string-name>. (<year>2011</year>). <article-title>The Lin28/let-7 Axis Regulates Glucose Metabolism</article-title>. <source>Cell</source>, <volume>147</volume>(<issue>1</issue>), <fpage>81</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.033</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92879.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rath</surname>
<given-names>Satyajit</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Indian Institute of Science Education and Research (IISER)</institution>
</institution-wrap>
<city>Pune</city>
<country>India</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>important</bold> study indicates a significant role for individual let-7 miRNA clusters in regulating generation of Tc17 CD8 cells and emphysema severity in a mouse model. The authors provide <bold>convincing</bold> evidence for let-7-mediated repression of the transcription factor RORgt and consequent modulation of IL-17-producing CD8 T cells, with correlated data from human emphysema material, though the most effective let-7 cluster/s is/are yet to be tested for its/their ability to modulate disease. The findings, which substantially advance the understanding of roles that let-7 miRNA clusters play in modulating both T cell responses and emphysematous lung disease, will be of interest to T cell and lung disease researchers.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92879.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary: Inflammatory T cells have been recognized to play an important role in human COPD lung tissue and animal models of emphysema. The authors have previously identified that Th17 cells regulate chronic inflammatory diseases, including in mice exposed to smoke or nanoparticulate carbon black (nCB). Here, the authors interrogate the role of Tc17 cells using similar mouse models. Investigating let-7 miRNA, which induces antigen-presenting cells activation and T cell mediated Th17a inflammation, they show that the master regulator of Tc17/Th17 differentiation, RAR-related orphan receptor gamma t (RORγt), is a direct target of let-7 miRNA in T cells. Because RORγt expression is elevated in COPD patients and in mouse models of COPD, the authors generate a Let-7 overexpressing mouse in T cells and reduce RORγt expression and Th17 and Tc17 cell recruitment in nCB-exposed mice.</p>
<p>Strengths: The authors use previous a previously published RNA-seq dataset (GSE57148) from the lungs of control and COPD subjects to explore the involvement of Let-7 in emphysema. They further evaluate Let-7a expression by qPCR in lung tissue samples of smokers with emphysema and non-emphysema controls. Moreover, expression of Let-7a, Let-7b, Let-7d, and Let-7f in purified CD4+ T cells were inversely correlated with emphysema severity lungs. Similar findings were found in their mouse models (CS or nCB) in both lung tissue and isolated lung CD4+ and CD8+ T cells, with reduced let-7afd and let-7bc2 expression.</p>
<p>Using mice harboring a conditional deletion of the let-7bc2 cluster in all T cells (let-7bc2LOF) derived from the CD4+CD8+ double-positive stage, the authors show enhanced emphysema in nCB- or CS-exposed mice with enhanced recruitment of macrophages and neutrophils to the lung. While CD8+IL17a+ Tc17 cells and CD4+ IL17a+ Th17 cells were increased in nCB-exposed control animals, only let-7bc2LOF mice showed an increase in CD8+IL17a+ Tc17 cells. Further, unexposed let-7bc2LOF and let-7afdLOF mice expressed greater RORγt expression in both CD8+ and CD4+ T cells.</p>
<p>Generating a let-7 gain of function mouse with overexpression of let-7g in thymic double-positive-derived T cells, protein levels of RORγt were suppressed in CD8+ and CD4+ T cells of let-7GOF mice relative to controls. Let-7GOF mice treated with nCB showed similar lung alveolar distension as controls suggesting that increased let-7 expression does not protect the lung from emphysema. However, let-7GOF mice showed reduced lung Tc17 and Th17 cell populations and were resistant to the induction of RORγt after nCB exposure.</p>
<p>Weaknesses: Limited data is shown on the let-7afdLOF mice. Does this mouse respond similarly to nCB as the let-7bc2LOF.</p>
<p>
Because the authors validate their findings from a previously published RNA-seq dataset in subjects with and without emphysema, the authors should include patient demographics from the data presented in Figure 1C-D.</p>
<p>
To validate their mouse models, the absence of Let-7 or enhanced Let-7 expression needs to be shown in isolated T cells from exposed mice.</p>
<p>
In Figure 3, the authors are missing the unexposed let-7bc2LOF group from all panels. This is again an issue in Figure 6 with the let-7GOF.</p>
<p>
Because the GOF mouse enhances Let-7g within T cells, the importance of Let-7g should be determined in human subjects. Why did the authors choose to overexpress Let-7g, the rational is not clear?</p>
<p>
The purity of the CD4+ and CD8+ T cells is not shown and the full gating strategy should be included.</p>
<p>
The authors indicate that Tc17 and Th17 T cells were reduced in the GOF mouse, it remains unclear if macrophage or neutrophil recruitment is altered in GOF mice.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92879.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
Let-7 family miRNAs are largely redundant in function, and originate from multiple genomic loci (&quot;clusters&quot;). Erice et al demonstrate that two individual clusters (let7afd and let7bc2) in mice regulate the generation of IL-17 producing CD8 T cells in vitro and in vivo in a model of emphysema. These cells also express higher levels of the IL-17-inducing transcription factor RORgt, encoded by Rorc, which the authors demonstrate to be a direct target of let-7. Since multiple let-7 family miRNAs are downregulated in T cells and lung tissue in emphysema, these data support a model in which reduced let-7 allows increased IL-17 production by T cells, contributing to disease pathogenesis.</p>
<p>Strengths:</p>
<p>
The inclusion of miRNA and pri-miRNA expression data from sorted human lung T cells as well as mouse T cells from an emphysema model is a strength.</p>
<p>The study includes complementary loss of function and gain of function experimental systems to test the effect of altered let-7 function, though it should be noted that these involved different let-7 family members and did not yield simple, complementary results for all experimental outcomes.</p>
<p>The most important finding is that deletion of just one let-7 cluster (&quot;Let7bc2&quot;) is sufficient to exacerbate emphysema in the nCB and CS models.</p>
<p>Weaknesses:</p>
<p>
The functional analyses are unusually focused on IL-17 producing CD8 T cells, but it is not made clear whether these cells are an important player in emphysema pathogenesis in the nCB and CS models. The data shown reveal that they are far less numerous than IL-17-producing CD4 T cells. It is also notable that the Figure 1 expression data from human subjects used sorted CD4+ T cells. And as the author mentioned, prior work on let-7 showed that it regulated Th17 (CD4) responses.</p>
<p>Compared with Let7bc2 deletion, Let7afd deletion had a much larger effect on IL17 production by CD8 T cells in vitro, and it also had a larger effect on RORgt expression in untreated mice in vivo, especially in the lung. It would be valuable to more thoroughly characterize the let7afd mice. RORgt expression should be shown in the in vitro assays. In the results, the authors state that let7afdLOF mice &quot;did not exhibit lung histopathology nor inflammatory changes&quot; up to 6 months of age. Similarly, it is stated in the conclusion that &quot;the let-7afdLOF mice ... did not exhibit changes in Tc17/Th17 subpopulations&quot; in vivo. All these data should be shown, and if no baseline changes are apparent, then I also recommend challenging these mice with nCB and/or cigarette smoke.</p>
<p>This brings up the larger issue of redundancy among the let-7 family members and genomic clusters. This should be discussed, including some explanation of the relative expression of each mature family member in T cells, and how that maps to the clusters studied here (and those that were not investigated). It would also be helpful to explain the relationship between mouse Let7bc2 and human Let7a3b, since Let7bc2 is the primary focus of emphysema experiments in this manuscript.</p>
<p>This is especially important because the study of individual let-7 clusters is the core novelty of this body of work, as described in the first paragraph of the discussion. The regulation of let-7 expression has been reported before and its functional role has been investigated with a variety of tools.</p>
<p>Let7g overexpression caused a marked reduction in Rorgt expression in T cells at baseline and in the setting of nCB challenge, and it reduced the frequency of IL17+ producing CD8 T cells in the lung to baseline levels. Yet there was no change in the MLI measurement of histopathology. Is this a robust result? The responses in the experiment shown in Fig. 6C-D are quite muted compared to those shown in Figure 2. The latter also shows a larger number of replicates, and it is unclear whether the data in 6D include measurement from all of the mice tested (e.g. pooled from 2 small experiments) or only mice from one experiment.</p>
<p>Although RORgt is a great candidate to have direct effects on IL-17 expression, the mechanistic understanding of let-7 action on T cell differentiation and cytokine production is limited to this single target. As noted in the discussion, others have identified cytokine receptor targets that may play a role, but it is also likely others among the many targets of let-7 also contribute.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.92879.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary: The manuscript by Erice et al describes let-7 miRNA promotes Tc17 differentiation and emphysema by repressing the transcription factor RORgt. The authors found that overall expression of the let-7 miRNA clusters, let-7b/let-7c2 and let-7a1/let-30 7f1/let-7d are reduced in the lungs and T cells of mice with cigarette smoke-induced emphysema. They also found that the loss of the let-7b/let-7c2-cluster in T cells exaggerated cigarette smoke-induced emphysema. It appears that deletion of the let-7b/let-7c2-cluster lead to enhancement of IL-17-secreting CD8+ T cells (Tc17) in mice with emphysema. The opposite phenotype was observed when let-7 was overexpressed in T cells. They found a potential let-7 binding site in the 3' UTR of RORgt. They demonstrated a direct effect of let-7 on RORgt expression using let-7 mimic in a RORgt luciferase reporter assay. They have done an outstanding job of translating the finding of reduced let-7 expression in emphysema patients to a thorough delineation of its mechanism in a mouse model. Together, this study suggests an important role for let-7 miRNA in Tc17 cells in emphysema which appears to be mediated via repression of RORgt.</p>
<p>Strengths: This well written manuscript flows logically and the data supports the overall claim let-7 miRNA promotes Tc17 differentiation during emphysema. There are several strengths to this study including the use of conditional let-7 knock out animals to decipher the role of this miRNA in Tc17 cells in emphysema.</p>
<p>Weaknesses: There are no major weaknesses in this study. It would be interesting to see if knockdown RORgt could rescue enhanced Tc17 differentiation seen in let-7b/let-7c2-cluster-deficient T cells. The authors show no change in frequencies of Treg cells in let-7bc2LOF mice exposed to nCB. Do these Treg cells also express higher levels of RORgt and IL-17? The major question that was not addressed in this study is how let-7 expression is regulated in emphysema. The other recommendation is that the authors include the sequences of the let-7 mimic oligos used in the luciferase assay.</p>
</body>
</sub-article>
</article>